Page 10: HIV and AIDS in Canada: Surveillance Report to December 31, 2014 - Data tables
Data tables
Year of test | Number of cases reported to PHAC |
---|---|
1985-1995 | 35,766 |
1996 | 2,729 |
1997 | 2,460 |
1998 | 2,290 |
1999 | 2,184 |
2000 | 2,092 |
2001 | 2,216 |
2002 | 2,460 |
2003 | 2,468 |
2004 | 2,520 |
2005 | 2,476 |
2006 | 2,537 |
2007 | 2,439 |
2008 | 2,620 |
2009 | 2,391 |
2010 | 2,330 |
2011 | 2,290 |
2012 | 2,081 |
2013 | 2,076 |
2014 | 2,044 |
Total | 80,469 |
Age and sex | Number of cases reported | %Footnote 2 |
---|---|---|
Children (< 15 years old) | 650 | 0.8 |
Males | 362 | 57.5 |
Females | 268 | 42.5 |
Sex not reported/transsexual/transgender | 20 | |
Adults (≥ 15 years old)Footnote 3 | 76,281 | 99.2 |
Males | 61,131 | 81.5 |
Females | 13,866 | 18.5 |
Sex not reported/transsexual/transgender | 1,284 | |
Age group not reported | 3,538 | |
Males | 1,993 | |
Females | 174 | |
Sex not reported/transsexual/transgender | 1,371 | |
Total | 80,469 | 100.0 |
Males | 63,486 | 81.6 |
Females | 14,308 | 18.4 |
Sex not reported/transsexual/transgender | 2,675 |
Males | Females | Sex not reported/ transsexual/transgender |
Total | |||||
---|---|---|---|---|---|---|---|---|
Year of test | Number of cases | Cumulative total | Number of cases | Cumulative total | Number of cases | Cumulative total | Number of cases | Cumulative total |
1985-2003 | 42,007 | 42,007 | 7,564 | 7,564 | 1,204 | 1,204 | 50,775 | 50,775 |
2004 | 1,834 | 43,841 | 647 | 8,211 | 3 | 1,207 | 2,484 | 53,259 |
2005 | 1,812 | 45,653 | 618 | 8,829 | 5 | 1,212 | 2,435 | 55,694 |
2006 | 1,812 | 47,465 | 692 | 9,521 | 6 | 1,218 | 2,510 | 58,204 |
2007 | 1,800 | 49,265 | 600 | 10,121 | 8 | 1,226 | 2,408 | 60,612 |
2008 | 1,917 | 51,182 | 665 | 10,786 | 4 | 1,230 | 2,586 | 63,198 |
2009 | 1,755 | 52,937 | 604 | 11,390 | 7 | 1,237 | 2,366 | 65,564 |
2010 | 1,761 | 54,698 | 527 | 11,917 | 14 | 1,251 | 2,302 | 67,866 |
2011 | 1,724 | 56,422 | 533 | 12,450 | 11 | 1,262 | 2,268 | 70,134 |
2012 | 1,578 | 58,000 | 480 | 12,930 | 5 | 1,267 | 2,063 | 72,197 |
2013 | 1,600 | 59,600 | 442 | 13,372 | 9 | 1,276 | 2,051 | 74,248 |
2014 | 1,531 | 61,131 | 494 | 13,866 | 8 | 1,284 | 2,033 | 76,281 |
TotalFootnote 1 | 61,131 | 13,866 | 1,284 | 76,281 |
Age group | Year of test | Total | |||||||
---|---|---|---|---|---|---|---|---|---|
1985-2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | n | %Footnote 2 | |
Children < 15 years | 556 | 20 | 16 | 12 | 16 | 21 | 9 | 650 | 0.8 |
Adults | 63,198 | 2,366 | 2,302 | 2,268 | 2,063 | 2,051 | 2,033 | 76,281 | 99.2 |
15 to 19 years | 1,000 | 48 | 31 | 45 | 36 | 39 | 37 | 1,236 | 1.6 |
20 to 29 years | 16,055 | 530 | 523 | 516 | 478 | 460 | 437 | 18,999 | 24.7 |
30 to 39 years | 25,040 | 715 | 718 | 694 | 608 | 604 | 645 | 29,024 | 37.7 |
40 to 49 years | 14,066 | 716 | 612 | 582 | 575 | 514 | 466 | 17,531 | 22.8 |
≥ 50 years | 6,120 | 357 | 418 | 431 | 366 | 434 | 448 | 8,574 | 11.1 |
Adult, age unknownFootnote 3 | 917 | 0 | 0 | 0 | 0 | 0 | 0 | 917 | 1.2 |
Subtotal | 63,754 | 2,386 | 2,318 | 2,280 | 2,079 | 2,072 | 2,042 | 76,931 | 100.0 |
Age group not reported | 3,503 | 5 | 12 | 10 | 2 | 4 | 2 | 3,538 | |
Total | 67,257 | 2,391 | 2,330 | 2,290 | 2,081 | 2,076 | 2,044 | 80,469 |
Age group | Year of test | Total | |||||||
---|---|---|---|---|---|---|---|---|---|
1985-2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | n | %Footnote 2 | |
Male children < 15 years | 320 | 7 | 8 | 5 | 9 | 10 | 3 | 362 | 0.6 |
Adult males | 51,182 | 1,755 | 1,761 | 1,724 | 1,578 | 1,600 | 1,531 | 61,131 | 99.4 |
15 to 19 years | 560 | 21 | 15 | 21 | 22 | 26 | 24 | 689 | 1.1 |
20 to 29 years | 12,183 | 372 | 386 | 384 | 359 | 359 | 350 | 14,393 | 23.4 |
30 to 39 years | 20,514 | 492 | 522 | 496 | 440 | 440 | 466 | 23,370 | 38.0 |
40 to 49 years | 11,978 | 575 | 507 | 462 | 461 | 411 | 351 | 14,745 | 24.0 |
≥ 50 years | 5,171 | 295 | 331 | 361 | 296 | 364 | 340 | 7,158 | 11.6 |
Adult, age unknownFootnote 3 | 776 | 0 | 0 | 0 | 0 | 0 | 0 | 776 | 1.3 |
Subtotal | 51,502 | 1,762 | 1,769 | 1,729 | 1,587 | 1,610 | 1,534 | 61,493 | 100.0 |
Age group not reported | 1,977 | 2 | 6 | 4 | 1 | 2 | 1 | 1,993 | |
TotalFootnote 4 | 53,479 | 1,764 | 1,775 | 1,733 | 1,588 | 1,612 | 1,535 | 63,486 |
Age group | Year of test | Total | |||||||
---|---|---|---|---|---|---|---|---|---|
1985-2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | n | %Footnote 2 | |
Female children < 15 years | 216 | 13 | 8 | 7 | 7 | 11 | 6 | 268 | 1.9 |
Adult females | 10,786 | 604 | 527 | 533 | 480 | 442 | 494 | 13,866 | 98.1 |
15 to 19 years | 427 | 27 | 16 | 23 | 14 | 13 | 13 | 533 | 3.8 |
20 to 29 years | 3,573 | 158 | 133 | 129 | 117 | 100 | 85 | 4,295 | 30.4 |
30 to 39 years | 4,046 | 221 | 190 | 195 | 166 | 162 | 176 | 5,156 | 36.5 |
40 to 49 years | 1,842 | 137 | 104 | 117 | 114 | 100 | 114 | 2,528 | 17.9 |
≥ 50 years | 811 | 61 | 84 | 69 | 69 | 67 | 106 | 1,267 | 9.0 |
Adult, age unknownFootnote 3 | 87 | 0 | 0 | 0 | 0 | 0 | 0 | 87 | 0.6 |
Subtotal | 11,002 | 617 | 535 | 540 | 487 | 453 | 500 | 14,134 | 100.0 |
Age group not reported | 172 | 0 | 2 | 0 | 0 | 0 | 0 | 174 | |
TotalFootnote 4 | 11,174 | 617 | 537 | 540 | 487 | 453 | 500 | 14,308 |
Exposure category | Year of test | Total | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1985-2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | ||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | %Footnote 2 | |
MSM | 19,792 | 55.4 | 660 | 41.4 | 707 | 46.1 | 668 | 45.0 | 666 | 46.6 | 672 | 48.4 | 652 | 48.8 | 23,817 | 53.5 |
MSM/IDU | 919 | 2.6 | 50 | 3.1 | 39 | 2.5 | 36 | 2.4 | 30 | 2.1 | 37 | 2.7 | 37 | 2.8 | 1,148 | 2.6 |
IDU | 6,202 | 17.4 | 316 | 19.8 | 268 | 17.5 | 263 | 17.7 | 215 | 15.0 | 188 | 13.5 | 175 | 13.1 | 7,627 | 17.1 |
Blood/blood productsFootnote 3 | ||||||||||||||||
a) recipient of blood/clotting factor | 139 | 0.4 | 1 | 0.1 | 1 | 0.1 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 141 | 0.3 |
b) recipient of blood | 316 | 0.9 | 6 | 0.4 | 2 | 0.1 | 2 | 0.1 | 3 | 0.2 | 2 | 0.1 | 2 | 0.1 | 333 | 0.7 |
c) recipient of clotting factor | 315 | 0.9 | 1 | 0.1 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 316 | 0.7 |
Heterosexual contact | ||||||||||||||||
a) origin from an HIV-endemic country | 2,398 | 6.7 | 191 | 12.0 | 145 | 9.5 | 160 | 10.8 | 176 | 12.3 | 131 | 9.4 | 133 | 10.0 | 3,334 | 7.5 |
b) sexual contact with a person at risk | 2,415 | 6.8 | 162 | 10.2 | 186 | 12.1 | 158 | 10.7 | 143 | 10.0 | 150 | 10.8 | 123 | 9.2 | 3,337 | 7.5 |
c) NIR-Het | 2,873 | 8.0 | 194 | 12.2 | 153 | 10.0 | 150 | 10.1 | 133 | 9.3 | 135 | 9.7 | 134 | 10.0 | 3,772 | 8.5 |
OtherFootnote 4 | 356 | 1.0 | 12 | 0.8 | 31 | 2.0 | 46 | 3.1 | 63 | 4.4 | 74 | 5.3 | 80 | 6.0 | 662 | 1.5 |
Subtotal | 35,725 | 100.0 | 1,593 | 100.0 | 1,532 | 100.0 | 1,483 | 100.0 | 1,429 | 100.0 | 1,389 | 100.0 | 1,336 | 100.0 | 44,487 | 100.0 |
NIR | 3,340 | 97 | 73 | 88 | 65 | 40 | 74 | 3,777 | ||||||||
Not reported | 24,133 | 676 | 697 | 697 | 569 | 622 | 623 | 28,017 | ||||||||
TotalFootnote 5 | 63,198 | 2,366 | 2,302 | 2,268 | 2,063 | 2,051 | 2,033 | 76,281 |
Exposure category | Year of test | Total | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1985-2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | ||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | %Footnote 2 | |
MSM | 19,701 | 66.9 | 660 | 56.4 | 707 | 59.4 | 668 | 59.2 | 666 | 61.6 | 672 | 61.8 | 652 | 63.3 | 23,726 | 65.6 |
MSM/IDU | 917 | 3.1 | 50 | 4.3 | 39 | 3.3 | 36 | 3.2 | 30 | 2.8 | 37 | 3.4 | 37 | 3.6 | 1,146 | 3.2 |
IDU | 4,061 | 13.8 | 187 | 16.0 | 165 | 13.9 | 161 | 14.3 | 129 | 11.9 | 123 | 11.3 | 99 | 9.6 | 4,925 | 13.6 |
Blood/blood productsFootnote 3 | ||||||||||||||||
a) recipient of blood/clotting factor | 105 | 0.4 | 0 | 0.0 | 1 | 0.1 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 106 | 0.3 |
b) recipient of blood | 198 | 0.7 | 6 | 0.5 | 1 | 0.1 | 1 | 0.1 | 2 | 0.2 | 1 | 0.1 | 2 | 0.2 | 211 | 0.6 |
c) recipient of clotting factor | 269 | 0.9 | 1 | 0.1 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 270 | 0.7 |
Heterosexual contact | ||||||||||||||||
a) origin from an HIV-endemic country | 1,049 | 3.6 | 66 | 5.6 | 67 | 5.6 | 79 | 7.0 | 61 | 5.6 | 47 | 4.3 | 56 | 5.4 | 1,425 | 3.9 |
b) sexual contact with a person at risk | 1,148 | 3.9 | 78 | 6.7 | 96 | 8.1 | 79 | 7.0 | 65 | 6.0 | 75 | 6.9 | 61 | 5.9 | 1,602 | 4.4 |
c) NIR-Het | 1,745 | 5.9 | 118 | 10.1 | 95 | 8.0 | 78 | 6.9 | 92 | 8.5 | 95 | 8.7 | 78 | 7.6 | 2,301 | 6.4 |
OtherFootnote 4 | 262 | 0.9 | 4 | 0.3 | 19 | 1.6 | 26 | 2.3 | 37 | 3.4 | 38 | 3.5 | 45 | 4.4 | 431 | 1.2 |
Subtotal | 29,455 | 100.0 | 1,170 | 100.0 | 1,190 | 100.0 | 1,128 | 100.0 | 1,082 | 100.0 | 1,088 | 100.0 | 1,030 | 100.0 | 36,143 | 100.0 |
NIR | 2,604 | 69 | 51 | 63 | 50 | 32 | 49 | 2,918 | ||||||||
Not reported | 19,123 | 516 | 520 | 533 | 446 | 480 | 452 | 22,070 | ||||||||
TotalFootnote 5 | 51,182 | 1,755 | 1,761 | 1,724 | 1,578 | 1,600 | 1,531 | 61,131 |
Exposure category | Year of test | Total | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1985-2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | ||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | %Footnote 2 | |
IDU | 2,089 | 34.4 | 129 | 30.5 | 103 | 30.2 | 102 | 28.8 | 86 | 24.8 | 64 | 21.5 | 74 | 24.5 | 2,647 | 32.5 |
Blood/blood productsFootnote 3 | ||||||||||||||||
a) recipient of blood/clotting factor | 34 | 0.6 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 35 | 0.4 |
b) recipient of blood | 113 | 1.9 | 0 | 0.0 | 1 | 0.3 | 1 | 0.3 | 1 | 0.3 | 1 | 0.3 | 0 | 0.0 | 117 | 1.4 |
c) recipient of clotting factor | 33 | 0.5 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 33 | 0.4 |
Heterosexual contact | ||||||||||||||||
a) origin from an HIV-endemic country | 1,343 | 22.1 | 125 | 29.6 | 77 | 22.6 | 80 | 22.6 | 115 | 33.1 | 83 | 27.9 | 77 | 25.5 | 1,900 | 23.3 |
b) sexual contact with a person at risk | 1,249 | 20.5 | 84 | 19.9 | 90 | 26.4 | 79 | 22.3 | 78 | 22.5 | 74 | 24.8 | 61 | 20.2 | 1,715 | 21.1 |
c) NIR-Het | 1,128 | 18.6 | 76 | 18.0 | 58 | 17.0 | 72 | 20.3 | 41 | 11.8 | 40 | 13.4 | 55 | 18.2 | 1,470 | 18.1 |
OtherFootnote 4 | 90 | 1.5 | 8 | 1.9 | 12 | 3.5 | 20 | 5.6 | 26 | 7.5 | 36 | 12.1 | 35 | 11.6 | 227 | 2.8 |
Subtotal | 6,079 | 100.0 | 423 | 100.0 | 341 | 100.0 | 354 | 100.0 | 347 | 100.0 | 298 | 100.0 | 302 | 100.0 | 8,144 | 100.0 |
NIR | 575 | 25 | 19 | 25 | 13 | 8 | 23 | 688 | ||||||||
Not reported | 4,132 | 156 | 167 | 154 | 120 | 136 | 169 | 5,034 | ||||||||
TotalFootnote 5 | 10,786 | 604 | 527 | 533 | 480 | 442 | 494 | 13,866 |
Exposure category | Year of test | Total | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1985-2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | |||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | %Footnote 3 | ||
Blood/blood productsFootnote 4 | |||||||||||||||||
a) recipient of blood/clotting factor | 4 | 1.1 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 4 | 1.0 | |
b) recipient of blood | 20 | 5.4 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 20 | 4.8 | |
c) recipient of clotting factor | 67 | 18.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 67 | 16.1 | |
|
239 | 64.2 | 10 | 100.0 | 6 | 75.0 | 4 | 57.1 | 0 | 0.0 | 5 | 45.5 | 1 | 25.0 | 265 | 63.5 | |
OtherFootnote 5 | 42 | 11.3 | 0 | 0.0 | 2 | 25.0 | 3 | 42.9 | 5 | 100.0 | 6 | 54.5 | 3 | 75.0 | 61 | 14.6 | |
Subtotal | 372 | 100.0 | 10 | 100.0 | 8 | 100.0 | 7 | 100.0 | 5 | 100.0 | 11 | 100.0 | 4 | 100.0 | 417 | 100.0 | |
NIR | 16 | 0 | 1 | 0 | 0 | 2 | 0 | 19 | |||||||||
Not reported | 168 | 10 | 7 | 5 | 11 | 8 | 5 | 214 | |||||||||
Total | 556 | 20 | 16 | 12 | 16 | 21 | 9 | 650 |
Exposure category | Age group (years) | ||||||
---|---|---|---|---|---|---|---|
15-19 | 20-29 | 30-39 | 40-49 | ≥ 50 | Age group not reported | Total | |
MSM | 11 | 202 | 227 | 118 | 94 | 0 | 652 |
MSM/IDU | 0 | 10 | 12 | 9 | 6 | 1 | 38 |
IDU | 2 | 27 | 50 | 55 | 41 | 0 | 175 |
Blood/blood productsFootnote 2 | 0 | 0 | 1 | 0 | 1 | 0 | 2 |
Heterosexual contact | |||||||
a) origin from an HIV-endemic country | 4 | 14 | 61 | 33 | 21 | 0 | 133 |
b) sexual contact with a person at risk | 2 | 16 | 32 | 34 | 39 | 0 | 123 |
c) NIR-Het | 3 | 23 | 43 | 24 | 41 | 0 | 134 |
OtherFootnote 3 | 2 | 13 | 28 | 20 | 17 | 0 | 80 |
NIR | 1 | 11 | 21 | 20 | 21 | 0 | 74 |
Not reported | 12 | 121 | 170 | 153 | 167 | 1 | 624 |
Total | 37 | 437 | 645 | 466 | 448 | 2 | 2,035 |
Race/ethnicity | Year of test | Total | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1998-2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | ||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | %Footnote 4 | |
Aboriginal | ||||||||||||||||
a) First Nations | 1,510 | 18.5 | 224 | 15.8 | 184 | 13.6 | 220 | 16.7 | 200 | 14.9 | 158 | 12.3 | 147 | 12.3 | 2,643 | 16.5 |
b) Métis | 174 | 2.1 | 33 | 2.3 | 19 | 1.4 | 20 | 1.5 | 14 | 1.0 | 12 | 0.9 | 23 | 1.9 | 295 | 1.8 |
c) Inuit | 19 | 0.2 | 0 | 0.0 | 1 | 0.1 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.1 | 21 | 0.1 |
d) Aboriginal, unspecified | 334 | 4.1 | 41 | 2.9 | 60 | 4.4 | 43 | 3.3 | 37 | 2.8 | 56 | 4.4 | 22 | 1.8 | 593 | 3.7 |
South Asian/West Asian/ArabFootnote 5 | 199 | 2.4 | 47 | 3.3 | 39 | 2.9 | 42 | 3.2 | 67 | 5.0 | 45 | 3.5 | 53 | 4.4 | 492 | 3.1 |
AsianFootnote 6 | 282 | 3.5 | 71 | 5.0 | 72 | 5.3 | 76 | 5.8 | 80 | 6.0 | 76 | 5.9 | 82 | 6.9 | 739 | 4.6 |
BlackFootnote 7 | 816 | 10.0 | 237 | 16.7 | 208 | 15.4 | 240 | 18.2 | 295 | 22.0 | 214 | 16.7 | 235 | 19.7 | 2,245 | 14.0 |
Latin AmericanFootnote 8 | 180 | 2.2 | 77 | 5.4 | 55 | 4.1 | 66 | 5.0 | 47 | 3.5 | 69 | 5.4 | 65 | 5.5 | 559 | 3.5 |
White | 4,591 | 56.3 | 669 | 47.2 | 698 | 51.6 | 588 | 44.6 | 575 | 43.0 | 632 | 49.4 | 536 | 45.0 | 8,289 | 51.6 |
Other | 46 | 0.6 | 18 | 1.3 | 17 | 1.3 | 24 | 1.8 | 23 | 1.7 | 18 | 1.4 | 28 | 2.3 | 174 | 1.1 |
Subtotal | 8,151 | 100.0 | 1,417 | 100.0 | 1,353 | 100.0 | 1,319 | 100.0 | 1,338 | 100.0 | 1,280 | 100.0 | 1,192 | 100.0 | 16,050 | 100.0 |
Not reported | 18,151 | 974 | 977 | 971 | 743 | 796 | 852 | 23,464 | ||||||||
Total | 26,302 | 2,391 | 2,330 | 2,290 | 2,081 | 2,076 | 2,044 | 39,514 |
Race/ethnicity | Year of test | Total | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1998-2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | ||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | %Footnote 4 | |
Aboriginal | ||||||||||||||||
a) First Nations | 753 | 12.8 | 120 | 11.6 | 92 | 8.9 | 122 | 12.3 | 122 | 12.1 | 89 | 8.9 | 83 | 9.1 | 1,381 | 11.6 |
b) Métis | 101 | 1.7 | 17 | 1.6 | 12 | 1.2 | 13 | 1.3 | 5 | 0.5 | 12 | 1.2 | 15 | 1.7 | 175 | 1.5 |
c) Inuit | 14 | 0.2 | 0 | 0.0 | 1 | 0.1 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.1 | 16 | 0.1 |
d) Aboriginal, unspecified | 177 | 3.0 | 21 | 2.0 | 37 | 3.6 | 21 | 2.1 | 19 | 1.9 | 29 | 2.9 | 8 | 0.9 | 312 | 2.6 |
South Asian/West Asian/ArabFootnote 5 | 154 | 2.6 | 41 | 4.0 | 32 | 3.1 | 38 | 3.8 | 57 | 5.7 | 38 | 3.8 | 43 | 4.7 | 403 | 3.4 |
AsianFootnote 6 | 240 | 4.1 | 58 | 5.6 | 59 | 5.7 | 69 | 7.0 | 73 | 7.3 | 73 | 7.3 | 73 | 8.0 | 645 | 5.4 |
BlackFootnote 7 | 394 | 6.7 | 113 | 10.9 | 116 | 11.3 | 130 | 13.1 | 149 | 14.8 | 108 | 10.8 | 135 | 14.9 | 1,145 | 9.6 |
Latin AmericanFootnote 8 | 167 | 2.8 | 69 | 6.7 | 51 | 4.9 | 61 | 6.2 | 45 | 4.5 | 65 | 6.5 | 61 | 6.7 | 519 | 4.4 |
White | 3,860 | 65.5 | 584 | 56.3 | 619 | 60.0 | 516 | 52.1 | 519 | 51.6 | 570 | 56.9 | 465 | 51.2 | 7,133 | 60.1 |
Other | 35 | 0.6 | 14 | 1.4 | 12 | 1.2 | 20 | 2.0 | 17 | 1.7 | 17 | 1.7 | 24 | 2.6 | 139 | 1.2 |
Subtotal | 5,895 | 100.0 | 1,037 | 100.0 | 1,031 | 100.0 | 990 | 100.0 | 1,006 | 100.0 | 1,001 | 100.0 | 908 | 100.0 | 11,868 | 100.0 |
Not reported | 13,556 | 727 | 744 | 743 | 582 | 611 | 627 | 17,590 | ||||||||
TotalFootnote 9 | 19,451 | 1,764 | 1,775 | 1,733 | 1,588 | 1,612 | 1,535 | 29,458 |
Race/ethnicity | Year of test | Total | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1998-2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | ||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | %Footnote 4 | |
Aboriginal | ||||||||||||||||
a) First Nations | 753 | 33.6 | 104 | 27.6 | 92 | 28.7 | 98 | 29.8 | 78 | 23.6 | 69 | 24.9 | 64 | 22.8 | 1,258 | 30.3 |
b) Métis | 73 | 3.3 | 16 | 4.2 | 7 | 2.2 | 7 | 2.1 | 9 | 2.7 | 0 | 0.0 | 8 | 2.8 | 120 | 2.9 |
c) Inuit | 5 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 5 | 0.1 |
d) Aboriginal, unspecified | 157 | 7.0 | 20 | 5.3 | 23 | 7.2 | 22 | 6.7 | 18 | 5.5 | 27 | 9.7 | 14 | 5.0 | 281 | 6.8 |
South Asian/West Asian/ArabFootnote 5 | 45 | 2.0 | 5 | 1.3 | 7 | 2.2 | 4 | 1.2 | 10 | 3.0 | 7 | 2.5 | 10 | 3.6 | 88 | 2.1 |
AsianFootnote 6 | 42 | 1.9 | 13 | 3.4 | 13 | 4.0 | 7 | 2.1 | 7 | 2.1 | 3 | 1.1 | 9 | 3.2 | 94 | 2.3 |
BlackFootnote 7 | 421 | 18.8 | 124 | 32.9 | 91 | 28.3 | 110 | 33.4 | 146 | 44.2 | 105 | 37.9 | 100 | 35.6 | 1,097 | 26.4 |
Latin AmericanFootnote 8 | 12 | 0.5 | 8 | 2.1 | 4 | 1.2 | 5 | 1.5 | 2 | 0.6 | 4 | 1.4 | 4 | 1.4 | 39 | 0.9 |
White | 724 | 32.3 | 83 | 22.0 | 79 | 24.6 | 72 | 21.9 | 55 | 16.7 | 61 | 22.0 | 68 | 24.2 | 1,142 | 27.5 |
Other | 11 | 0.5 | 4 | 1.1 | 5 | 1.6 | 4 | 1.2 | 5 | 1.5 | 1 | 0.4 | 4 | 1.4 | 34 | 0.8 |
Subtotal | 2,243 | 100.0 | 377 | 100.0 | 321 | 100.0 | 329 | 100.0 | 330 | 100.0 | 277 | 100.0 | 281 | 100.0 | 4,158 | 100.0 |
Not reported | 4,354 | 240 | 216 | 211 | 157 | 176 | 219 | 5,573 | ||||||||
TotalFootnote 9 | 6,597 | 617 | 537 | 540 | 487 | 453 | 500 | 9,731 |
Race/ethnicity | Heterosexual contact | Total | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MSM | MSM/IDU | IDU | Blood/blood products | a) origin from an HIV-endemic country | b) sexual contact with a person at risk | c) NIR-Het | Perinatal transmission | Other | NIR | Not reported | ||||||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | %Footnote 5 | |
Aboriginal | ||||||||||||||||||||||||
a) First Nations | 156 | 2.6 | 79 | 17.8 | 1,587 | 40.7 | 3 | 5.1 | 2 | 0.1 | 389 | 20.4 | 315 | 19.9 | 14 | 29.8 | 28 | 8.1 | 35 | 14.3 | 35 | 20.8 | 2,643 | 16.5 |
b) Métis | 23 | 0.4 | 14 | 3.1 | 182 | 4.7 | 2 | 3.4 | 0 | 0.0 | 37 | 1.9 | 28 | 1.8 | 1 | 2.1 | 4 | 1.2 | 3 | 1.2 | 1 | 0.6 | 295 | 1.8 |
c) Inuit | 4 | 0.1 | 1 | 0.2 | 5 | 0.1 | 0 | 0.0 | 1 | 0.1 | 3 | 0.2 | 7 | 0.4 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 21 | 0.1 |
d) Aboriginal, unspecified | 52 | 0.9 | 12 | 2.7 | 202 | 5.2 | 7 | 11.9 | 0 | 0.0 | 268 | 14.0 | 14 | 0.9 | 1 | 2.1 | 2 | 0.6 | 34 | 13.9 | 1 | 0.6 | 593 | 3.7 |
South Asian/West Asian/ArabFootnote 6 | 183 | 3.1 | 8 | 1.8 | 46 | 1.2 | 5 | 8.5 | 11 | 0.8 | 78 | 4.1 | 116 | 7.3 | 2 | 4.3 | 4 | 1.2 | 32 | 13.1 | 7 | 4.2 | 492 | 3.1 |
AsianFootnote 7 | 472 | 7.9 | 9 | 2.0 | 22 | 0.6 | 1 | 1.7 | 30 | 2.1 | 78 | 4.1 | 94 | 5.9 | 0 | 0.0 | 19 | 5.5 | 6 | 2.5 | 8 | 4.8 | 739 | 4.6 |
BlackFootnote 8 | 287 | 4.8 | 13 | 2.9 | 47 | 1.2 | 12 | 20.3 | 1,315 | 93.8 | 194 | 10.2 | 133 | 8.4 | 16 | 34.0 | 200 | 58.1 | 16 | 6.6 | 12 | 7.1 | 2,245 | 14.0 |
Latin AmericanFootnote 9 | 401 | 6.7 | 6 | 1.3 | 20 | 0.5 | 2 | 3.4 | 11 | 0.8 | 42 | 2.2 | 51 | 3.2 | 0 | 0.0 | 14 | 4.1 | 8 | 3.3 | 4 | 2.4 | 559 | 3.5 |
White | 4,278 | 72.0 | 299 | 67.2 | 1,772 | 45.4 | 26 | 44.1 | 19 | 1.4 | 808 | 42.3 | 805 | 50.8 | 10 | 21.3 | 66 | 19.2 | 107 | 43.9 | 99 | 58.9 | 8,289 | 51.6 |
Other | 85 | 1.4 | 4 | 0.9 | 21 | 0.5 | 1 | 1.7 | 13 | 0.9 | 13 | 0.7 | 23 | 1.5 | 3 | 6.4 | 7 | 2.0 | 3 | 1.2 | 1 | 0.6 | 174 | 1.1 |
Subtotal | 5,941 | 100.0 | 445 | 100.0 | 3,904 | 100.0 | 59 | 100.0 | 1,402 | 100.0 | 1,910 | 100.0 | 1,586 | 100.0 | 47 | 100.0 | 344 | 100.0 | 244 | 100.0 | 168 | 100.0 | 16,050 | 100.0 |
Not reported | 4,709 | 224 | 949 | 40 | 1,725 | 563 | 1,291 | 84 | 30 | 1,071 | 12,778 | 23,464 | ||||||||||||
Total | 10,650 | 669 | 4,853 | 99 | 3,127 | 2,473 | 2,877 | 131 | 374 | 1,315 | 12,946 | 39,514 |
Aboriginal | Total | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
a) First Nations | b) Métis | c) Inuit | d) Aboriginal, unspecified | South Asian/West Asian/ArabFootnote 5 | AsianFootnote 6 | BlackFootnote 7 | Latin AmericanFootnote 8 | White | Other | Not reported | ||||||||||||||
Exposure Category | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | %Footnote 9 |
MSM | 156 | 6.1 | 23 | 7.9 | 4 | 19.0 | 52 | 9.3 | 183 | 40.4 | 472 | 65.1 | 287 | 12.9 | 401 | 73.3 | 4278 | 52.9 | 85 | 50.0 | 4709 | 49.0 | 10,650 | 42.2 |
MSM/IDU | 79 | 3.1 | 14 | 4.8 | 1 | 4.8 | 12 | 2.2 | 8 | 1.8 | 9 | 1.2 | 13 | 0.6 | 6 | 1.1 | 299 | 3.7 | 4 | 2.4 | 224 | 2.3 | 669 | 2.6 |
IDU | 1,587 | 61.7 | 182 | 62.5 | 5 | 23.8 | 202 | 36.2 | 46 | 10.2 | 22 | 3.0 | 47 | 2.1 | 20 | 3.7 | 1,772 | 21.9 | 21 | 12.4 | 949 | 9.9 | 4,853 | 19.2 |
Blood/blood products | 3 | 0.1 | 2 | 0.7 | 0 | 0.0 | 7 | 1.3 | 5 | 1.1 | 1 | 0.1 | 12 | 0.5 | 2 | 0.4 | 26 | 0.3 | 1 | 0.6 | 40 | 0.4 | 99 | 0.4 |
Heterosexual contact | ||||||||||||||||||||||||
a) origin from an HIV-endemic country | 2 | 0.1 | 0 | 0.0 | 1 | 4.8 | 0 | 0.0 | 11 | 2.4 | 30 | 4.1 | 1,315 | 59.3 | 11 | 2.0 | 19 | 0.2 | 13 | 7.6 | 1,725 | 17.9 | 3,127 | 12.4 |
b) sexual contact with a person at risk | 389 | 15.1 | 37 | 12.7 | 3 | 14.3 | 268 | 48.0 | 78 | 17.2 | 78 | 10.8 | 194 | 8.8 | 42 | 7.7 | 808 | 10.0 | 13 | 7.6 | 563 | 5.9 | 2,473 | 9.8 |
c) NIR-Het | 315 | 12.2 | 28 | 9.6 | 7 | 33.3 | 14 | 2.5 | 116 | 25.6 | 94 | 13.0 | 133 | 6.0 | 51 | 9.3 | 805 | 10.0 | 23 | 13.5 | 1,291 | 13.4 | 2,877 | 11.4 |
Perinatal transmission | 14 | 0.5 | 1 | 0.3 | 0 | 0.0 | 1 | 0.2 | 2 | 0.4 | 0 | 0.0 | 16 | 0.7 | 0 | 0.0 | 10 | 0.1 | 3 | 1.8 | 84 | 0.9 | 131 | 0.5 |
Other | 28 | 1.1 | 4 | 1.4 | 0 | 0.0 | 2 | 0.4 | 4 | 0.9 | 19 | 2.6 | 200 | 9.0 | 14 | 2.6 | 66 | 0.8 | 7 | 4.1 | 30 | 0.3 | 374 | 1.5 |
Subtotal | 2,573 | 100.0 | 291 | 100.0 | 21 | 100.0 | 558 | 100.0 | 453 | 100.0 | 725 | 100.0 | 2,217 | 100.0 | 547 | 100.0 | 8,083 | 100.0 | 170 | 100.0 | 9,615 | 100.0 | 25,253 | 100.0 |
NIR | 35 | 3 | 0 | 34 | 32 | 6 | 16 | 8 | 107 | 3 | 1071 | 1,315 | ||||||||||||
Not reported | 35 | 1 | 0 | 1 | 7 | 8 | 12 | 4 | 99 | 1 | 12,778 | 12,946 | ||||||||||||
Total | 2,643 | 295 | 21 | 593 | 492 | 739 | 2,245 | 559 | 8,289 | 174 | 23,464 | 39,514 |
Province/territory | Year of test | Total | |||||||
---|---|---|---|---|---|---|---|---|---|
1985-2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | n | % | |
British Columbia | 13,349 | 337 | 300 | 288 | 237 | 267 | 262 | 15,040 | 18.7 |
Yukon | 50 | 3 | 1 | 1 | 1 | 1 | 3 | 60 | 0.1 |
Alberta | 5,029 | 219 | 204 | 224 | 242 | 261 | 276 | 6,455 | 8.0 |
Northwest Territories | 46 | - | - | - | - | - | - | 54 | 0.1 |
NunavutFootnote 2 | - | - | - | - | - | - | - | 3 | 0.0 |
Saskatchewan | 1,002 | 199 | 174 | 188 | 184 | 129 | 121 | 1,997 | 2.5 |
Manitoba | 1,542 | 103 | 121 | 77 | 71 | 118 | 85 | 2,117 | 2.6 |
Ontario | 29,577 | 996 | 1,025 | 1,003 | 869 | 815 | 837 | 35,122 | 43.6 |
QuebecFootnote 3 | 15,249 | 512 | 476 | 477 | 443 | 453 | 435 | 18,045 | 22.4 |
New Brunswick | 396 | 1 | 8 | 10 | 4 | 5 | 3 | 427 | 0.5 |
Nova Scotia | 722 | 13 | 15 | 15 | 18 | 16 | 10 | 809 | 1.0 |
Prince Edward Island | 42 | - | - | - | - | - | - | 50 | 0.1 |
Newfoundland and LabradorFootnote 4 | 250 | 6 | 5 | 3 | 9 | 7 | 10 | 290 | 0.4 |
Total | 67,257 | 2,391 | 2,330 | 2,290 | 2,081 | 2,076 | 2,044 | 80,469 | 100 |
Province/territory | Age group (years) | Total | |||||||
---|---|---|---|---|---|---|---|---|---|
0-4 | 5-9 | 10-14 | 15-19 | 20-29 | 30-39 | 40-49 | 50+ | n | |
British Columbia | 0 | 0 | 0 | 3 | 60 | 79 | 49 | 71 | 262 |
Yukon | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 3 |
Alberta | 1 | 0 | 0 | 3 | 58 | 93 | 63 | 58 | 276 |
Northwest Territories | - | - | - | - | - | - | - | - | - |
Nunavut | - | - | - | - | - | - | - | - | - |
Saskatchewan | 0 | 0 | 1 | 3 | 21 | 40 | 30 | 26 | 121 |
Manitoba | 1 | 0 | 0 | 2 | 15 | 28 | 24 | 15 | 85 |
Ontario | 1 | 0 | 1 | 17 | 200 | 288 | 175 | 153 | 835 |
QuebecFootnote 2 | 1 | 0 | 3 | 9 | 77 | 111 | 114 | 120 | 435 |
New Brunswick | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 3 |
Nova Scotia | 0 | 0 | 0 | 0 | 3 | 2 | 4 | 1 | 10 |
Prince Edward Island | - | - | - | - | - | - | - | - | - |
Newfoundland and LabradorFootnote 3 | 0 | 0 | 0 | 0 | 1 | 2 | 4 | 3 | 10 |
TotalFootnote 4 | 4 | 0 | 5 | 37 | 437 | 645 | 466 | 448 | 2,042 |
Province/territory | Year of test | ||||||||
---|---|---|---|---|---|---|---|---|---|
2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | |
British Columbia | 8.5 | 9.1 | 8.0 | 7.6 | 6.7 | 6.4 | 5.2 | 5.8 | 5.7 |
Yukon | 6.2 | 0.0 | 6.0 | 8.9 | 2.9 | 2.8 | 2.8 | 2.7 | 8.2 |
Alberta | 6.5 | 6.4 | 6.5 | 6.0 | 5.5 | 5.9 | 6.2 | 6.5 | 6.7 |
Northwest Territories | - | - | - | - | - | - | - | - | - |
Nunavut | - | - | - | - | - | - | - | - | - |
Saskatchewan | 10.2 | 12.7 | 17.1 | 19.2 | 16.5 | 17.6 | 16.9 | 11.7 | 10.8 |
Manitoba | 6.5 | 6.3 | 7.3 | 8.5 | 9.9 | 6.2 | 5.7 | 9.3 | 6.6 |
Ontario | 8.9 | 8.2 | 8.5 | 7.7 | 7.8 | 7.6 | 6.5 | 6.0 | 6.1 |
QuebecFootnote 3 | 7.7 | 6.9 | 8.2 | 6.5 | 6.0 | 6.0 | 5.5 | 5.6 | 5.3 |
New Brunswick | 2.5 | 1.9 | 1.9 | 0.1 | 1.1 | 1.3 | 0.5 | 0.7 | 0.4 |
Nova Scotia | 2.5 | 2.1 | 2.2 | 1.4 | 1.6 | 1.6 | 1.9 | 1.7 | 1.1 |
Prince Edward Island | - | - | - | - | - | - | - | - | - |
Newfoundland and LabradorFootnote 4 | 1.4 | 0.0 | 0.6 | 1.2 | 1.0 | 0.6 | 1.7 | 1.3 | 1.9 |
Total | 7.8 | 7.4 | 7.9 | 7.1 | 6.9 | 6.7 | 6.0 | 5.9 | 5.8 |
Province/territory | Year of test | Total | |||||||
---|---|---|---|---|---|---|---|---|---|
1985-2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | n | |
British Columbia | 10,804 | 287 | 266 | 238 | 245 | 208 | 235 | 216 | 12,499 |
Yukon | 35 | 1 | 2 | 0 | 1 | 1 | 1 | 2 | 43 |
Alberta | 3,867 | 152 | 150 | 148 | 154 | 173 | 180 | 187 | 5,011 |
Northwest Territories | - | - | - | - | - | - | - | - | 42 |
NunavutFootnote 2 | - | - | - | - | - | - | - | - | 3 |
Saskatchewan | 513 | 95 | 110 | 108 | 109 | 109 | 85 | 78 | 1,207 |
Manitoba | 1,096 | 53 | 57 | 84 | 47 | 42 | 71 | 52 | 1,502 |
Ontario | 23,353 | 825 | 762 | 813 | 779 | 674 | 671 | 656 | 28,533 |
QuebecFootnote 3 | 10,690 | 489 | 397 | 359 | 370 | 351 | 342 | 322 | 13,320 |
New Brunswick | 328 | 10 | 1 | 8 | 8 | 4 | 5 | 2 | 366 |
Nova Scotia | 604 | 19 | 11 | 12 | 13 | 18 | 13 | 10 | 700 |
Prince Edward Island | - | - | - | - | - | - | - | - | 29 |
Newfoundland and LabradorFootnote 4 | 193 | 3 | 6 | 5 | 3 | 7 | 6 | 8 | 231 |
TotalFootnote 5 | 51,544 | 1,935 | 1,764 | 1,775 | 1,733 | 1,588 | 1,612 | 1,535 | 63,486 |
Province/territory | Year of test | Total | |||||||
---|---|---|---|---|---|---|---|---|---|
1985-2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | n | |
British Columbia | 1,853 | 60 | 71 | 62 | 43 | 29 | 32 | 44 | 2,194 |
Yukon | 13 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 17 |
Alberta | 929 | 81 | 69 | 56 | 70 | 69 | 80 | 89 | 1,443 |
Northwest Territories | - | - | - | - | - | - | - | - | 12 |
NunavutFootnote 2 | - | - | - | - | - | - | - | - | 0 |
Saskatchewan | 305 | 79 | 89 | 66 | 79 | 75 | 44 | 43 | 780 |
Manitoba | 358 | 35 | 46 | 37 | 30 | 29 | 47 | 33 | 615 |
Ontario | 4,095 | 270 | 225 | 194 | 209 | 190 | 138 | 174 | 5,495 |
QuebecFootnote 3 | 2,723 | 144 | 114 | 117 | 105 | 91 | 107 | 113 | 3,514 |
New Brunswick | 54 | 4 | 0 | 0 | 2 | 0 | 0 | 1 | 61 |
Nova Scotia | 97 | 2 | 2 | 3 | 2 | 0 | 3 | 0 | 109 |
Prince Edward Island | - | - | - | - | - | - | - | - | 9 |
Newfoundland and LabradorFootnote 4 | 54 | 0 | 0 | 0 | 0 | 2 | 1 | 2 | 59 |
TotalFootnote 5 | 10,498 | 676 | 617 | 537 | 540 | 487 | 453 | 500 | 14,308 |
Province/territory | Year of test | ||||||||
---|---|---|---|---|---|---|---|---|---|
2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | |
British Columbia | 13.8 | 14.2 | 13.3 | 12.1 | 10.7 | 11.0 | 9.2 | 10.3 | 9.4 |
Yukon | 12.1 | 0.0 | 5.9 | 11.6 | 0.0 | 5.5 | 5.4 | 5.4 | 10.7 |
Alberta | 8.5 | 8.8 | 8.3 | 8.0 | 7.8 | 8.0 | 8.8 | 8.8 | 8.9 |
Northwest Territories | - | - | - | - | - | - | - | - | - |
Nunavut | - | - | - | - | - | - | - | - | - |
Saskatchewan | 9.8 | 13.1 | 18.8 | 21.3 | 20.5 | 20.4 | 19.9 | 15.3 | 13.7 |
Manitoba | 8.3 | 8.6 | 8.9 | 9.5 | 13.9 | 7.7 | 6.8 | 11.3 | 8.2 |
Ontario | 12.7 | 12.8 | 13.0 | 11.9 | 12.6 | 12.0 | 10.2 | 10.1 | 9.8 |
QuebecFootnote 3 | 11.8 | 10.6 | 12.7 | 10.2 | 9.1 | 9.3 | 8.7 | 8.4 | 7.9 |
New Brunswick | 3.8 | 2.5 | 2.7 | 0.3 | 2.2 | 2.1 | 1.1 | 1.3 | 0.5 |
Nova Scotia | 4.6 | 4.0 | 4.2 | 2.4 | 2.6 | 2.8 | 3.9 | 2.8 | 2.2 |
Prince Edward Island | - | - | - | - | - | - | - | - | - |
Newfoundland and LabradorFootnote 4 | 2.4 | 0.0 | 1.2 | 2.4 | 1.9 | 1.2 | 2.7 | 2.3 | 3.1 |
TotalFootnote 5 | 11.3 | 11.1 | 11.7 | 10.6 | 10.5 | 10.2 | 9.2 | 9.2 | 8.7 |
Province/territory | Females | ||||||||
---|---|---|---|---|---|---|---|---|---|
2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | |
British Columbia | 3.4 | 3.9 | 2.7 | 3.2 | 2.8 | 1.9 | 1.3 | 1.4 | 1.9 |
Yukon | 0.0 | 0.0 | 6.2 | 6.1 | 5.9 | 0.0 | 0.0 | 0.0 | 5.6 |
Alberta | 4.4 | 3.9 | 4.6 | 3.8 | 3.0 | 3.7 | 3.6 | 4.1 | 4.4 |
Northwest Territories | - | - | - | - | - | - | - | - | - |
Nunavut | - | - | - | - | - | - | - | - | - |
Saskatchewan | 10.6 | 12.3 | 15.4 | 17.2 | 12.6 | 14.9 | 13.9 | 8.0 | 7.7 |
Manitoba | 4.7 | 4.0 | 5.8 | 7.6 | 6.0 | 4.8 | 4.6 | 7.4 | 5.1 |
Ontario | 5.1 | 3.6 | 4.1 | 3.4 | 2.9 | 3.1 | 2.8 | 2.0 | 2.5 |
QuebecFootnote 3 | 3.6 | 3.2 | 3.7 | 2.9 | 2.9 | 2.6 | 2.2 | 2.6 | 2.7 |
New Brunswick | 1.3 | 1.3 | 1.1 | 0.0 | 0.0 | 0.5 | 0.0 | 0.0 | 0.3 |
Nova Scotia | 0.4 | 0.4 | 0.4 | 0.4 | 0.6 | 0.4 | 0.0 | 0.6 | 0.0 |
Prince Edward Island | - | - | - | - | - | - | - | - | - |
Newfoundland and LabradorFootnote 4 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.7 | 0.4 | 0.7 |
TotalFootnote 5 | 4.3 | 3.7 | 4.0 | 3.6 | 3.1 | 3.1 | 2.8 | 2.6 | 2.8 |
Exposure category | Province/territory | Total | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BC | YT | AB | NT | NU | SK | MB | ON | QCFootnote 2 | NB | NS | PE | NL | n | %Footnote 3 | |
MSM | 144 | 2 | 78 | - | - | 15 | 17 | 379 | NR | 1 | 9 | - | 6 | 651 | 48.5 |
MSM/IDU | 2 | 0 | 9 | - | - | 0 | 0 | 26 | NR | 0 | 1 | - | 0 | 38 | 2.8 |
IDU | 19 | 0 | 31 | - | - | 55 | 12 | 58 | NR | 0 | 0 | - | 0 | 175 | 13.0 |
Blood/blood productsFootnote 4 | 1 | 0 | 0 | - | - | 1 | 0 | 0 | NR | 0 | 0 | - | 0 | 2 | 0.1 |
Heterosexual contact | |||||||||||||||
a) origin from an HIV-endemic country | 0 | 0 | 29 | - | - | 11 | 13 | 78 | NR | 2 | 0 | - | 2 | 135 | 10.1 |
b) sexual contact with a person at risk | 27 | 0 | 31 | - | - | 19 | 17 | 27 | NR | 0 | 0 | - | 2 | 123 | 9.2 |
c) NIR-Het | 35 | 1 | 27 | - | - | 12 | 0 | 59 | NR | 0 | 0 | - | 0 | 134 | 10.0 |
Other | 4 | 0 | 70 | - | - | 6 | 0 | 1 | NR | 0 | 0 | - | 0 | 81 | 6.0 |
Subtotal | 232 | 3 | 275 | - | - | 119 | 59 | 628 | 0 | 3 | 10 | - | 10 | 1,341 | 99.9 |
NIR | 2 | 0 | 0 | - | - | 2 | 26 | 44 | 0 | 0 | 0 | - | 0 | 74 | |
Not reported | 28 | 0 | 1 | - | - | 0 | 0 | 165 | 435 | 0 | 0 | - | 0 | 629 | |
Total | 262 | 3 | 276 | - | - | 121 | 85 | 837 | 435 | 3 | 10 | - | 10 | 2,044 |
Tested in CanadaFootnote 1 | Tested overseasFootnote 2 | |||
---|---|---|---|---|
Number diagnosed with HIV | % | Number diagnosed with HIV | % | |
YearFootnote 3 | ||||
2002 | 265 | 8.8 | - | - |
2003 | 366 | 12.2 | - | - |
2004 | 329 | 11.0 | - | - |
2005 | 282 | 9.4 | 149 | 14.1 |
2006 | 373 | 12.4 | 161 | 15.2 |
2007 | 308 | 10.3 | 111 | 10.5 |
2008 | 365 | 12.2 | 183 | 17.3 |
2009 | 275 | 9.2 | 84 | 7.9 |
2010 | 231 | 7.7 | 111 | 10.5 |
2011 | 210 | 7.0 | 119 | 11.2 |
2012 | - | - | 140 | 13.2 |
Sex | ||||
Male | 1,702 | 56.7 | 504 | 47.6 |
Female | 1,302 | 43.3 | 554 | 52.4 |
Age group | ||||
<15 | 16 | 0.5 | 55 | 5.2 |
15-19 | 45 | 1.5 | 45 | 4.3 |
20-29 | 736 | 24.5 | 281 | 26.6 |
30-39 | 1,277 | 42.5 | 443 | 41.9 |
40-49 | 713 | 23.7 | 195 | 18.4 |
50+ | 217 | 7.2 | 39 | 3.7 |
ProvinceFootnote 4 | ||||
AB | 174 | 5.8 | 160 | 15.1 |
BC | 253 | 8.4 | 137 | 12.9 |
MB | 83 | 2.8 | 96 | 9.1 |
ON | 1,633 | 54.4 | 354 | 33.5 |
QC | 807 | 26.9 | 258 | 24.4 |
SK | 23 | 0.8 | 31 | 2.9 |
Atlantic provincesFootnote 5 | 31 | 1.0 | 22 | 2.1 |
HIV-endemic country | ||||
Yes | 2,020 | 67.2 | 735 | 69.5 |
No | 984 | 32.8 | 323 | 30.5 |
Total | 3,004 | 100.0 | 1,058 | 100.0% |
Maternal exposure category | Year of birth | Total | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1984-2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | ||||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | %Footnote 1 | |
IDU | 571 | 25.4 | 53 | 26.8 | 38 | 17.6 | 32 | 17.4 | 43 | 19.3 | 47 | 21.3 | 34 | 16.6 | 34 | 18.1 | 37 | 17.0 | 889 | 22.8 |
Blood products/ transfusion/ medical | 38 | 1.7 | 2 | 1.0 | 4 | 1.9 | 5 | 2.7 | 5 | 2.2 | 1 | 0.5 | 3 | 1.5 | 8 | 4.3 | 5 | 2.3 | 71 | 1.8 |
Heterosexual contact | 1,624 | 72.3 | 137 | 69.2 | 172 | 79.6 | 143 | 77.7 | 172 | 77.1 | 173 | 78.3 | 165 | 80.5 | 142 | 75.5 | 164 | 75.2 | 2,892 | 74.2 |
Mother-to-childFootnote 2 | 1 | 0.0 | 4 | 2.0 | 1 | 0.5 | 3 | 1.6 | 3 | 1.3 | 0 | 0.0 | 3 | 1.5 | 3 | 1.6 | 6 | 2.8 | 24 | 0.6 |
Other | 11 | 0.5 | 2 | 1.0 | 1 | 0.5 | 1 | 0.5 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.5 | 6 | 2.8 | 22 | 0.6 |
NIR | 226 | 14 | 26 | 16 | 26 | 15 | 24 | 19 | 15 | 381 | ||||||||||
Total | 2,471 | 100.0 | 212 | 100.0 | 242 | 100.0 | 200 | 100.0 | 249 | 100.0 | 236 | 100.0 | 229 | 100.0 | 207 | 100.0 | 233 | 100.0 | 4,279 | 100.0 |
Maternal exposure category | Year of birth | Total | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
1984-2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | |||
No perinatal ART prophylaxis | |||||||||||
Confirmed infected | 541 | 10 | 5 | 7 | 8 | 4 | 1 | 2 | 0 | 578 | |
Asymptomatic | 71 | 10 | 2 | 6 | 7 | 4 | 1 | 2 | 0 | 103 | |
Symptomatic | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18 | |
Died of AIDS | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100 | |
Died of other | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | |
Lost to follow-upFootnote 1 | 155 | 0 | 3 | 1 | 1 | 0 | 0 | 0 | 0 | 160 | |
Adult careFootnote 2 | 187 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 187 | |
Confirmed not infected | 444 | 19 | 15 | 15 | 10 | 7 | 9 | 5 | 4 | 528 | |
Infection status not confirmed | 27 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 29 | |
Indeterminate | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Lost to follow-up | 27 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 29 | |
Subtotal | 1,012 | 29 | 20 | 22 | 18 | 12 | 11 | 7 | 4 | 1,135 | |
Any perinatal ART prophylaxis | |||||||||||
Confirmed infected | 18 | 1 | 1 | 1 | 4 | 2 | 0 | 0 | 2 | 29 | |
Asymptomatic | 3 | 1 | 0 | 0 | 2 | 2 | 0 | 0 | 2 | 10 | |
Symptomatic | 3 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 4 | |
Died of AIDS | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |
Died of other | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |
Lost to follow-upFootnote 1 | 8 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 11 | |
Adult careFootnote 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | |
Confirmed not infected | 1,390 | 177 | 214 | 171 | 220 | 215 | 214 | 194 | 207 | 3,002 | |
Infection status not confirmed | 23 | 1 | 2 | 1 | 1 | 1 | 2 | 3 | 18 | 52 | |
Indeterminate | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 17 | 17 | |
Lost to follow-up | 23 | 1 | 2 | 1 | 1 | 1 | 2 | 3 | 1 | 35 | |
Subtotal | 1,431 | 179 | 217 | 173 | 225 | 218 | 216 | 197 | 227 | 3,083 | |
|
28 | 4 | 5 | 5 | 6 | 6 | 2 | 3 | 2 | 61 | |
Total | 2,471 | 212 | 242 | 200 | 249 | 236 | 229 | 207 | 233 | 4,279 |
Confirmed infected | "Confirmed not infected" | Infection status not confirmed | Total | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Asymptomatic | Symptomatic | Died of AIDS | Died of other | LFUFootnote 1 | Adult care | Subtotal | Indeterminate | LFU | Subtotal | n | % | ||
BC | 22 | 2 | 4 | 2 | 3 | 32 | 65 | 503 | 0 | 7 | 7 | 575 | 13.4 |
Alberta | 25 | 0 | 5 | 1 | 16 | 14 | 61 | 505 | 2 | 17 | 19 | 585 | 13.7 |
Saskatchewan | 16 | 0 | 1 | 0 | 0 | 3 | 20 | 184 | 4 | 1 | 5 | 209 | 4.9 |
Manitoba | 0 | 0 | 1 | 0 | 5 | 2 | 8 | 209 | 1 | 1 | 2 | 219 | 5.1 |
Ontario | 23 | 11 | 40 | 6 | 112 | 55 | 247 | 1,223 | 8 | 14 | 22 | 1,492 | 34.9 |
Quebec | 39 | 13 | 44 | 1 | 37 | 81 | 215 | 911 | 2 | 24 | 26 | 1,152 | 26.9 |
Atlantic | 2 | 0 | 5 | 1 | 1 | 4 | 13 | 31 | 0 | 1 | 1 | 45 | 1.1 |
Yukon/NWT | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 2 | 0.0 |
Total | 127 | 26 | 101 | 11 | 174 | 191 | 630 | 3,567 | 17 | 65 | 82 | 4,279 | 100.0 |
% of subtotal | 20.2 | 4.1 | 16.0 | 1.7 | 27.6 | 30.3 | 100.0 | 100.0 | 20.7 | 79.3 | 100.0 | ||
% of total | 3.0 | 0.6 | 2.4 | 0.3 | 4.1 | 4.5 | 14.7 | 83.4 | 0.4 | 1.5 | 1.9 |
Year of birth | Total | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1984-1996 | 1997-2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | |||||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | |
White | 295 | 36.7 | 431 | 25.9 | 45 | 21.2 | 46 | 19.0 | 32 | 16.0 | 51 | 20.5 | 37 | 15.7 | 40 | 17.5 | 37 | 17.9 | 54 | 23.2 | 1,068 | 25.0 |
Prospective cohort | ||||||||||||||||||||||
Confirmed infected | 29 | 16.4 | 8 | 2.0 | 0 | 0.0 | 1 | 2.2 | 0 | 0.0 | 4 | 8.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 42 | 4.6 |
Confirmed not infected | 148 | 83.6 | 397 | 98.0 | 44 | 100.0 | 44 | 97.8 | 29 | 100.0 | 46 | 92.0 | 35 | 100.0 | 39 | 100.0 | 37 | 100.0 | 48 | 100.0 | 867 | 95.4 |
Retrospective cohort | ||||||||||||||||||||||
Confirmed infected | 76 | 69.7 | 8 | 50.0 | 1 | 100.0 | 0 | 0.0 | 2 | 100.0 | 0 | 0.0 | 1 | 50.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 88 | 66.7 |
Confirmed not infected | 33 | 30.3 | 8 | 50.0 | 0 | 0.0 | 1 | 100.0 | 0 | 0.0 | 1 | 100.0 | 1 | 50.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 44 | 33.3 |
Infection status not confirmed | 9 | 10 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 6 | 27 | |||||||||||
BlackFootnote 2 | 356 | 44.3 | 809 | 48.5 | 96 | 45.3 | 137 | 56.6 | 112 | 56.0 | 122 | 49.0 | 126 | 53.4 | 139 | 60.7 | 108 | 52.2 | 126 | 54.1 | 2,131 | 49.8 |
Prospective cohort | ||||||||||||||||||||||
Confirmed infected | 32 | 21.3 | 18 | 2.8 | 0 | 0.0 | 2 | 1.5 | 1 | 0.9 | 0 | 0.0 | 2 | 1.7 | 0 | 0.0 | 0 | 0.0 | 1 | 0.8 | 56 | 3.2 |
Confirmed not infected | 118 | 78.7 | 630 | 97.2 | 90 | 100.0 | 128 | 98.5 | 107 | 99.1 | 119 | 100.0 | 119 | 98.3 | 136 | 100.0 | 104 | 100.0 | 119 | 99.2 | 1,670 | 96.8 |
Retrospective cohort | ||||||||||||||||||||||
Confirmed infected | 170 | 85.4 | 122 | 79.7 | 5 | 100.0 | 3 | 42.9 | 2 | 66.7 | 3 | 100.0 | 3 | 100.0 | 1 | 50.0 | 1 | 100.0 | 0 | 0.0 | 310 | 82.4 |
Confirmed not infected | 29 | 14.6 | 31 | 20.3 | 0 | 0.0 | 4 | 57.1 | 1 | 33.3 | 0 | 0.0 | 0 | 0.0 | 1 | 50.0 | 0 | 0.0 | 0 | 0.0 | 66 | 17.6 |
Infection status not confirmed | 7 | 8 | 1 | 0 | 1 | 0 | 2 | 1 | 3 | 6 | 29 | |||||||||||
Latin AmericanFootnote 3 | 11 | 1.4 | 14 | 0.8 | 2 | 0.9 | 6 | 2.5 | 5 | 2.5 | 0 | 0.0 | 5 | 2.1 | 3 | 1.3 | 0 | 0.0 | 1 | 0.4 | 47 | 1.1 |
Prospective cohort | ||||||||||||||||||||||
Confirmed infected | 5 | 71.4 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 5 | 13.2 |
Confirmed not infected | 2 | 28.6 | 11 | 100.0 | 2 | 100.0 | 4 | 100.0 | 5 | 100.0 | 0 | 0.0 | 5 | 100.0 | 3 | 100.0 | 0 | 0.0 | 1 | 100.0 | 33 | 86.8 |
Retrospective cohort | ||||||||||||||||||||||
Confirmed infected | 4 | 100.0 | 1 | 50.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 5 | 83.3 |
Confirmed not infected | 0 | 0.0 | 1 | 50.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 16.7 |
Infection status not confirmed | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | |||||||||||
AboriginalFootnote 4 | 76 | 9.5 | 300 | 18.0 | 51 | 24.1 | 36 | 14.9 | 40 | 20.0 | 50 | 20.1 | 49 | 20.8 | 36 | 15.7 | 51 | 24.6 | 40 | 17.2 | 729 | 17.0 |
Prospective cohort | ||||||||||||||||||||||
Confirmed infected | 11 | 21.6 | 12 | 4.3 | 4 | 8.2 | 1 | 2.8 | 0 | 0.0 | 2 | 4.0 | 0 | 0.0 | 0 | 0.0 | 1 | 2.0 | 0 | 0.0 | 31 | 4.6 |
Confirmed not infected | 40 | 78.4 | 269 | 95.7 | 45 | 91.8 | 35 | 97.2 | 37 | 100.0 | 48 | 96.0 | 49 | 100.0 | 35 | 100.0 | 50 | 98.0 | 34 | 100.0 | 642 | 95.4 |
Retrospective cohort | ||||||||||||||||||||||
Confirmed infected | 14 | 63.6 | 5 | 45.5 | 1 | 50.0 | 0 | 0.0 | 1 | 33.3 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 21 | 55.3 |
Confirmed not infected | 8 | 36.4 | 6 | 54.5 | 1 | 50.0 | 0 | 0.0 | 2 | 66.7 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 17 | 44.7 |
Infection status not confirmed | 3 | 8 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 6 | 18 | |||||||||||
AsianFootnote 5 | 24 | 3.0 | 61 | 3.7 | 6 | 2.8 | 8 | 3.3 | 8 | 4.0 | 13 | 5.2 | 6 | 2.5 | 6 | 2.6 | 5 | 2.4 | 6 | 2.6 | 143 | 3.3 |
Prospective cohort | ||||||||||||||||||||||
Confirmed infected | 0 | 0.0 | 2 | 4.3 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 2 | 1.9 |
Confirmed not infected | 7 | 100.0 | 45 | 95.7 | 6 | 100.0 | 7 | 100.0 | 6 | 100.0 | 9 | 100.0 | 6 | 100.0 | 6 | 100.0 | 5 | 100.0 | 6 | 100.0 | 103 | 98.1 |
Retrospective cohort | ||||||||||||||||||||||
Confirmed infected | 15 | 88.2 | 10 | 71.4 | 0 | 0.0 | 1 | 100.0 | 2 | 100.0 | 4 | 100.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 32 | 84.2 |
Confirmed not infected | 2 | 11.8 | 4 | 28.6 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 6 | 15.8 |
Infection status not confirmed | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||
OtherFootnote 6 | 10 | 1.2 | 22 | 1.3 | 4 | 1.9 | 4 | 1.7 | 1 | 0.5 | 7 | 2.8 | 8 | 3.4 | 5 | 2.2 | 5 | 2.4 | 4 | 1.7 | 70 | 1.6 |
Prospective cohort | ||||||||||||||||||||||
Confirmed infected | 1 | 25.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 1.7 |
Confirmed not infected | 3 | 75.0 | 17 | 100.0 | 4 | 100.0 | 4 | 100.0 | 1 | 100.0 | 6 | 100.0 | 8 | 100.0 | 5 | 100.0 | 5 | 100.0 | 4 | 100.0 | 57 | 98.3 |
Retrospective cohort | ||||||||||||||||||||||
Confirmed infected | 3 | 50.0 | 3 | 60.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 100.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 7 | 58.3 |
Confirmed not infected | 3 | 50.0 | 2 | 40.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 5 | 41.7 |
Infection status not confirmed | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||
Unknown | 32 | 4.0 | 30 | 1.8 | 8 | 3.8 | 5 | 2.1 | 2 | 1.0 | 6 | 2.4 | 5 | 2.1 | 0 | 0.0 | 1 | 0.5 | 2 | 0.9 | 91 | 2.1 |
Prospective cohort | ||||||||||||||||||||||
Confirmed infected | 1 | 100.0 | 2 | 14.3 | 0 | 0.0 | 0 | 0.0 | 2 | 100.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 5 | 12.5 |
Confirmed not infected | 0 | 0.0 | 12 | 85.7 | 8 | 100.0 | 5 | 100.0 | 0 | 0.0 | 5 | 100.0 | 4 | 100.0 | 0 | 0.0 | 0 | 0.0 | 1 | 100.0 | 35 | 87.5 |
Retrospective cohort | ||||||||||||||||||||||
Confirmed infected | 10 | 33.3 | 13 | 100.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 100.0 | 0 | 0.0 | 0 | 0.0 | 1 | 100.0 | 25 | 54.3 |
Confirmed not infected | 20 | 66.7 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 100.0 | 0 | 0.0 | 21 | 45.7 |
Infection status not confirmed | 1 | 3 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 5 | |||||||||||
Total | 804 | 100.0 | 1,667 | 100.0 | 212 | 100.0 | 242 | 100.0 | 200 | 100.0 | 249 | 100.0 | 236 | 100.0 | 229 | 100.0 | 207 | 100.0 | 233 | 100.0 | 4,279 | 100.0 |
Prospective cohort | ||||||||||||||||||||||
Confirmed infected | 79 | 19.9 | 42 | 3.0 | 4 | 2.0 | 4 | 1.7 | 3 | 1.6 | 6 | 2.5 | 2 | 0.9 | 0 | 0.0 | 1 | 0.5 | 1 | 0.5 | 142 | 4.0 |
Confirmed not infected | 318 | 80.1 | 1,381 | 97.0 | 199 | 98.0 | 227 | 98.3 | 185 | 98.4 | 233 | 97.5 | 226 | 99.1 | 224 | 100.0 | 201 | 99.5 | 213 | 99.5 | 3,407 | 96.0 |
Retrospective cohort | ||||||||||||||||||||||
Confirmed infected | 292 | 75.5 | 162 | 75.7 | 7 | 87.5 | 4 | 44.4 | 7 | 70.0 | 8 | 88.9 | 5 | 83.3 | 1 | 50.0 | 1 | 50.0 | 1 | 100.0 | 488 | 75.3 |
Confirmed not infected | 95 | 24.5 | 52 | 24.3 | 1 | 12.5 | 5 | 55.6 | 3 | 30.0 | 1 | 11.1 | 1 | 16.7 | 1 | 50.0 | 1 | 50.0 | 0 | 0.0 | 160 | 24.7 |
Infection status not confirmed | 20 | 30 | 1 | 2 | 2 | 1 | 2 | 3 | 3 | 18 | 82 |
Year of birth | Total | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1984-1996 | 1997-2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | |||||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | |
North America | 355 | 44.2 | 748 | 44.9 | 107 | 50.5 | 85 | 35.1 | 73 | 36.5 | 109 | 43.8 | 91 | 38.6 | 76 | 33.2 | 90 | 43.5 | 93 | 39.9 | 1,827 | 42.7 |
Prospective cohort | ||||||||||||||||||||||
Confirmed infected | 41 | 17.4 | 20 | 2.8 | 4 | 3.8 | 2 | 2.4 | 1 | 1.5 | 6 | 5.6 | 0 | 0.0 | 0 | 0.0 | 1 | 1.1 | 0 | 0.0 | 75 | 4.6 |
Confirmed not infected | 195 | 82.6 | 683 | 97.2 | 100 | 96.2 | 82 | 97.6 | 67 | 98.5 | 102 | 94.4 | 89 | 100.0 | 74 | 100.0 | 89 | 98.9 | 83 | 100.0 | 1,564 | 95.4 |
Retrospective cohort | ||||||||||||||||||||||
Confirmed infected | 73 | 67.0 | 13 | 48.1 | 2 | 66.7 | 0 | 0.0 | 2 | 50.0 | 0 | 0.0 | 1 | 50.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 91 | 62.3 |
Confirmed not infected | 36 | 33.0 | 14 | 51.9 | 1 | 33.3 | 1 | 100.0 | 2 | 50.0 | 0 | 0.0 | 1 | 50.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 55 | 37.7 |
Infection status not confirmed | 10 | 18 | 0 | 0 | 1 | 1 | 0 | 2 | 0 | 10 | 42 | |||||||||||
Africa | 179 | 22.3 | 621 | 37.3 | 83 | 39.2 | 116 | 47.9 | 92 | 46.0 | 100 | 40.2 | 106 | 44.9 | 113 | 49.3 | 96 | 46.4 | 100 | 42.9 | 1,606 | 37.5 |
Prospective cohort | ||||||||||||||||||||||
Confirmed infected | 11 | 22.4 | 13 | 2.7 | 0 | 0.0 | 2 | 1.8 | 0 | 0.0 | 0 | 0.0 | 2 | 1.9 | 0 | 0.0 | 0 | 0.0 | 1 | 1.1 | 29 | 2.2 |
Confirmed not infected | 38 | 77.6 | 470 | 97.3 | 78 | 100.0 | 109 | 98.2 | 89 | 100.0 | 99 | 100.0 | 101 | 98.1 | 112 | 100.0 | 92 | 100.0 | 94 | 98.9 | 1,282 | 97.8 |
Retrospective cohort | ||||||||||||||||||||||
Confirmed infected | 112 | 88.2 | 102 | 77.9 | 4 | 100.0 | 3 | 60.0 | 2 | 66.7 | 1 | 100.0 | 1 | 100.0 | 1 | 100.0 | 1 | 100.0 | 0 | 0.0 | 227 | 82.8 |
Confirmed not infected | 15 | 11.8 | 29 | 22.1 | 0 | 0.0 | 2 | 40.0 | 1 | 33.3 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 47 | 17.2 |
Infection status not confirmed | 3 | 7 | 1 | 0 | 0 | 0 | 2 | 0 | 3 | 5 | 21 | |||||||||||
Caribbean | 167 | 20.8 | 167 | 10.0 | 8 | 3.8 | 18 | 7.4 | 13 | 6.5 | 16 | 6.4 | 14 | 5.9 | 16 | 7.0 | 11 | 5.3 | 19 | 8.2 | 449 | 10.5 |
Prospective cohort | ||||||||||||||||||||||
Confirmed infected | 21 | 24.1 | 5 | 3.5 | 0 | 0.0 | 0 | 0.0 | 1 | 8.3 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 27 | 8.0 |
Confirmed not infected | 66 | 75.9 | 138 | 96.5 | 7 | 100.0 | 17 | 100.0 | 11 | 91.7 | 15 | 100.0 | 13 | 100.0 | 15 | 100.0 | 11 | 100.0 | 18 | 100.0 | 311 | 92.0 |
Retrospective cohort | ||||||||||||||||||||||
Confirmed infected | 60 | 78.9 | 18 | 78.3 | 1 | 100.0 | 0 | 0.0 | 0 | 0.0 | 1 | 100.0 | 1 | 100.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 81 | 78.6 |
Confirmed not infected | 16 | 21.1 | 5 | 21.7 | 0 | 0.0 | 1 | 100.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 22 | 21.4 |
Infection status not confirmed | 4 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 8 | |||||||||||
Central and South America | 18 | 2.2 | 24 | 1.4 | 2 | 0.9 | 5 | 2.1 | 6 | 3.0 | 1 | 0.4 | 5 | 2.1 | 4 | 1.7 | 0 | 0.0 | 2 | 0.9 | 67 | 1.6 |
Prospective cohort | ||||||||||||||||||||||
Confirmed infected | 4 | 44.4 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 4 | 7.5 |
Confirmed not infected | 5 | 55.6 | 21 | 100.0 | 2 | 100.0 | 4 | 100.0 | 6 | 100.0 | 0 | 0.0 | 5 | 100.0 | 4 | 100.0 | 0 | 0.0 | 2 | 100.0 | 49 | 92.5 |
Retrospective cohort | ||||||||||||||||||||||
Confirmed infected | 9 | 100.0 | 2 | 100.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 100.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 12 | 100.0 |
Confirmed not infected | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Infection status not confirmed | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | |||||||||||
Asia | 18 | 2.2 | 61 | 3.7 | 6 | 2.8 | 7 | 2.9 | 8 | 4.0 | 13 | 5.2 | 11 | 4.7 | 6 | 2.6 | 4 | 1.9 | 8 | 3.4 | 142 | 3.3 |
Prospective cohort | ||||||||||||||||||||||
Confirmed infected | 0 | 0.0 | 2 | 4.3 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 2 | 1.9 |
Confirmed not infected | 6 | 100.0 | 45 | 95.7 | 6 | 100.0 | 6 | 100.0 | 6 | 100.0 | 9 | 100.0 | 9 | 100.0 | 6 | 100.0 | 4 | 100.0 | 8 | 100.0 | 105 | 98.1 |
Retrospective cohort | ||||||||||||||||||||||
Confirmed infected | 12 | 100.0 | 11 | 84.6 | 0 | 0.0 | 1 | 100.0 | 2 | 100.0 | 4 | 100.0 | 2 | 100.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 32 | 94.1 |
Confirmed not infected | 0 | 0.0 | 2 | 15.4 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 2 | 5.9 |
Infection status not confirmed | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |||||||||||
Europe | 26 | 3.2 | 11 | 0.7 | 1 | 0.5 | 3 | 1.2 | 2 | 1.0 | 7 | 2.8 | 1 | 0.4 | 5 | 2.2 | 2 | 1.0 | 5 | 2.1 | 63 | 1.5 |
Prospective cohort | ||||||||||||||||||||||
Confirmed infected | 1 | 16.7 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 2.8 |
Confirmed not infected | 5 | 83.3 | 7 | 100.0 | 1 | 100.0 | 3 | 100.0 | 1 | 100.0 | 6 | 100.0 | 1 | 100.0 | 5 | 100.0 | 2 | 100.0 | 4 | 100.0 | 35 | 97.2 |
Retrospective cohort | ||||||||||||||||||||||
Confirmed infected | 15 | 78.9 | 3 | 100.0 | 0 | 0.0 | 0 | 0.0 | 1 | 100.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 19 | 79.2 |
Confirmed not infected | 4 | 21.1 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 100.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 5 | 20.8 |
Infection status not confirmed | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 3 | |||||||||||
Unknown | 41 | 5.1 | 35 | 2.1 | 5 | 2.4 | 8 | 3.3 | 6 | 3.0 | 3 | 1.2 | 8 | 3.4 | 9 | 3.9 | 4 | 1.9 | 6 | 2.6 | 125 | 2.9 |
Prospective cohort | ||||||||||||||||||||||
Confirmed infected | 1 | 25.0 | 2 | 10.5 | 0 | 0.0 | 0 | 0.0 | 1 | 16.7 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 4 | 6.2 |
Confirmed not infected | 3 | 75.0 | 17 | 89.5 | 5 | 100.0 | 6 | 100.0 | 5 | 83.3 | 2 | 100.0 | 8 | 100.0 | 8 | 100.0 | 3 | 100.0 | 4 | 100.0 | 61 | 93.8 |
Retrospective cohort | ||||||||||||||||||||||
Confirmed infected | 11 | 31.4 | 13 | 86.7 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 100.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 100.0 | 26 | 47.3 |
Confirmed not infected | 24 | 68.6 | 2 | 13.3 | 0 | 0.0 | 1 | 100.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 100.0 | 1 | 100.0 | 0 | 0.0 | 29 | 52.7 |
Infection status not confirmed | 2 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 5 | |||||||||||
Total | 804 | 100.0 | 1,667 | 100.0 | 212 | 100.0 | 242 | 100.0 | 200 | 100.0 | 249 | 100.0 | 236 | 100.0 | 229 | 100.0 | 207 | 100.0 | 233 | 100.0 | 4,279 | 100.0 |
Prospective cohort | ||||||||||||||||||||||
Confirmed infected | 79 | 19.9 | 42 | 3.0 | 4 | 2.0 | 4 | 1.7 | 3 | 1.6 | 6 | 2.5 | 2 | 0.9 | 0 | 0.0 | 1 | 0.5 | 1 | 0.5 | 142 | 4.0 |
Confirmed not infected | 318 | 80.1 | 1,381 | 97.0 | 199 | 98.0 | 227 | 98.3 | 185 | 98.4 | 233 | 97.5 | 226 | 99.1 | 224 | 100.0 | 201 | 99.5 | 213 | 99.5 | 3,407 | 96.0 |
Retrospective cohort | ||||||||||||||||||||||
Confirmed infected | 292 | 75.5 | 162 | 75.7 | 7 | 87.5 | 4 | 44.4 | 7 | 70.0 | 8 | 88.9 | 5 | 83.3 | 1 | 50.0 | 1 | 50.0 | 1 | 100.0 | 488 | 75.3 |
Confirmed not infected | 95 | 24.5 | 52 | 24.3 | 1 | 12.5 | 5 | 55.6 | 3 | 30.0 | 1 | 11.1 | 1 | 16.7 | 1 | 50.0 | 1 | 50.0 | 0 | 0.0 | 160 | 24.7 |
Infection status not confirmed | 20 | 30 | 1 | 2 | 2 | 1 | 2 | 3 | 3 | 18 | 82 |
Year of diagnosis of AIDS | Number of cases reported to PHAC |
---|---|
1979 | 2 |
1980 | 3 |
1981 | 10 |
1982 | 26 |
1983 | 64 |
1984 | 162 |
1985 | 403 |
1986 | 690 |
1987 | 1,014 |
1988 | 1,179 |
1989 | 1,411 |
1990 | 1,473 |
1991 | 1,533 |
1992 | 1,758 |
1993 | 1,838 |
1994 | 1,805 |
1995 | 1,676 |
1996 | 1,216 |
1997 | 753 |
1998 | 674 |
1999 | 585 |
2000 | 545 |
2001 | 457 |
2002 | 459 |
2003 | 429 |
2004 | 357 |
2005 | 434 |
2006 | 398 |
2007 | 371 |
2008 | 367 |
2009 | 296 |
2010 | 276 |
2011 | 234 |
2012 | 223 |
2013 | 226 |
2014 | 188 |
Total | 24,535 |
Age and sex | Number of cases reported | %Footnote 4 |
---|---|---|
Children (< 15 years) | 251 | 1.1 |
Males | 129 | 51.6 |
Females | 121 | 48.4 |
Sex not reported/transsexual/transgender | 1 | |
Adults (≥ 15 years) | 23,279 | 98.9 |
Males | 20,701 | 89.7 |
Females | 2,373 | 10.3 |
Sex not reported/transsexual/transgender | 205 | |
Age group not reported | 5 | 0.0 |
Males | 4 | 100.0 |
Females | 0 | 0.0 |
Sex not reported/transsexual/transgender | 1 | |
Total | 23,535 | 100.0 |
Males | 20,834 | 89.3 |
Females | 2,494 | 10.7 |
Sex not reported/transsexual/transgender | 207 |
Year of diagnosis | Males | Females | Sex not reported/ transsexual/transgender | Total | ||||
---|---|---|---|---|---|---|---|---|
No. of cases | Cumulative total | No. of cases | Cumulative total | No. of cases | Cumulative total | No. of cases | Cumulative total | |
1979-2004 | 18,418 | 18,418 | 1,784 | 1,784 | 84 | 84 | 20,286 | 20,286 |
2005 | 325 | 18,743 | 90 | 1,874 | 14 | 98 | 429 | 20,715 |
2006 | 307 | 19,050 | 79 | 1,953 | 9 | 107 | 395 | 21,110 |
2007 | 299 | 19,349 | 61 | 2,014 | 9 | 116 | 369 | 21,479 |
2008 | 277 | 19,626 | 84 | 2,098 | 4 | 120 | 365 | 21,844 |
2009 | 224 | 19,850 | 57 | 2,155 | 13 | 133 | 294 | 22,138 |
2010 | 214 | 20,064 | 49 | 2,204 | 10 | 143 | 273 | 22,411 |
2011 | 182 | 20,246 | 40 | 2,244 | 12 | 155 | 234 | 22,645 |
2012 | 172 | 20,418 | 36 | 2,280 | 14 | 169 | 222 | 22,867 |
2013 | 154 | 20,572 | 52 | 2,332 | 19 | 188 | 225 | 23,092 |
2014 | 129 | 20,701 | 41 | 2,373 | 17 | 205 | 187 | 23,279 |
Total | 20,701 | 2,373 | 205 | 23,279 |
Age group | Year of diagnosis | Total | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1979-2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | n | %Footnote 4 | |
Children | 232 | 5 | 3 | 2 | 2 | 1 | 3 | 0 | 1 | 1 | 1 | 251 | 1.1 |
< 1 year | 98 | 2 | 1 | 0 | 1 | 1 | 2 | 0 | 0 | 1 | 0 | 106 | 0.5 |
1 to 4 years | 69 | 1 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 73 | 0.3 |
5 to 9 years | 33 | 2 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 37 | 0.2 |
10 to 14 years | 32 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 35 | 0.1 |
Adults | 20,286 | 429 | 395 | 369 | 365 | 294 | 273 | 234 | 222 | 225 | 187 | 23,279 | 98.9 |
15 to 19 years | 72 | 3 | 2 | 3 | 1 | 2 | 2 | 2 | 3 | 3 | 1 | 94 | 0.4 |
20 to 24 years | 623 | 15 | 11 | 9 | 14 | 12 | 3 | 5 | 8 | 3 | 7 | 710 | 3.0 |
25 to 29 years | 2,582 | 36 | 32 | 20 | 26 | 23 | 16 | 13 | 6 | 18 | 10 | 2,782 | 11.8 |
30 to 34 years | 4,481 | 59 | 48 | 40 | 47 | 30 | 21 | 30 | 27 | 25 | 24 | 4,832 | 20.5 |
35 to 39 years | 4,439 | 78 | 75 | 67 | 59 | 47 | 38 | 34 | 28 | 19 | 23 | 4,907 | 20.9 |
40 to 44 years | 3,436 | 88 | 89 | 85 | 73 | 60 | 47 | 47 | 35 | 30 | 22 | 4,012 | 17.1 |
45 to 49 years | 2,194 | 63 | 60 | 62 | 59 | 54 | 52 | 46 | 41 | 48 | 40 | 2,719 | 11.6 |
50 to 54 years | 1,139 | 35 | 36 | 41 | 41 | 25 | 33 | 24 | 29 | 33 | 20 | 1,456 | 6.2 |
55 to 59 years | 672 | 30 | 21 | 18 | 22 | 24 | 31 | 12 | 16 | 20 | 20 | 886 | 3.8 |
≥ 60 years | 648 | 22 | 21 | 24 | 23 | 17 | 30 | 21 | 29 | 26 | 20 | 881 | 3.7 |
Subtotal | 20,518 | 434 | 398 | 371 | 367 | 295 | 276 | 234 | 223 | 226 | 188 | 23,530 | 100.0 |
Age group not reported | 4 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5 | |
Total | 20,522 | 434 | 398 | 371 | 367 | 296 | 276 | 234 | 223 | 226 | 188 | 23,535 |
Age group | Year of diagnosis | Total | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1979-2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | n | %Footnote 4 | |
Male children | 121 | 4 | 1 | 2 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 129 | 0.6 |
< 1 year | 45 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 46 | 0.2 |
1 to 4 years | 31 | 1 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35 | 0.2 |
5 to 9 years | 19 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 22 | 0.1 |
10 to 14 years | 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 26 | 0.1 |
Adult males | 18,418 | 325 | 307 | 299 | 277 | 224 | 214 | 182 | 172 | 154 | 129 | 20,701 | 99.4 |
15 to 19 years | 56 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 2 | 2 | 1 | 65 | 0.3 |
20 to 24 years | 492 | 11 | 8 | 4 | 10 | 8 | 1 | 2 | 4 | 2 | 5 | 547 | 2.6 |
25 to 29 years | 2,251 | 28 | 23 | 11 | 19 | 14 | 12 | 8 | 5 | 12 | 4 | 2,387 | 11.5 |
30 to 34 years | 4,048 | 44 | 29 | 25 | 29 | 19 | 14 | 23 | 21 | 18 | 16 | 4,286 | 20.6 |
35 to 39 years | 4,116 | 53 | 58 | 58 | 42 | 39 | 28 | 26 | 23 | 14 | 14 | 4,471 | 21.5 |
40 to 44 years | 3,186 | 68 | 73 | 76 | 59 | 46 | 41 | 40 | 26 | 21 | 12 | 3,648 | 17.5 |
45 to 49 years | 2,055 | 51 | 51 | 54 | 43 | 46 | 44 | 37 | 32 | 31 | 30 | 2,474 | 11.9 |
50 to 54 years | 1,069 | 27 | 29 | 35 | 35 | 22 | 28 | 22 | 23 | 24 | 15 | 1,329 | 6.4 |
55 to 59 years | 601 | 22 | 18 | 16 | 20 | 16 | 23 | 9 | 13 | 13 | 16 | 767 | 3.7 |
≥ 60 years | 544 | 20 | 17 | 19 | 20 | 13 | 23 | 15 | 23 | 17 | 16 | 727 | 3.5 |
Subtotal | 18,539 | 329 | 308 | 301 | 277 | 224 | 214 | 182 | 173 | 154 | 129 | 20,830 | 100.0 |
Age group not reported | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | |
TotalFootnote 5 | 18,543 | 329 | 308 | 301 | 277 | 224 | 214 | 182 | 173 | 154 | 129 | 20,834 |
Age group | Year of diagnosis | Total | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1979-2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | n | %Footnote 4 | |
Female children | 110 | 1 | 2 | 0 | 2 | 1 | 3 | 0 | 0 | 1 | 1 | 121 | 4.9 |
< 1 year | 53 | 1 | 1 | 0 | 1 | 1 | 2 | 0 | 0 | 1 | 0 | 60 | 2.4 |
1 to 4 years | 38 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38 | 1.5 |
5 to 9 years | 13 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 14 | 0.6 |
10 to 14 years | 6 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 9 | 0.4 |
Adult females | 1,784 | 90 | 79 | 61 | 84 | 57 | 49 | 40 | 36 | 52 | 41 | 2,373 | 95.1 |
15 to 19 years | 16 | 2 | 1 | 2 | 1 | 1 | 2 | 2 | 1 | 1 | 0 | 29 | 1.2 |
20 to 24 years | 131 | 4 | 3 | 5 | 4 | 4 | 2 | 3 | 4 | 1 | 2 | 163 | 6.5 |
25 to 29 years | 327 | 8 | 9 | 9 | 6 | 9 | 4 | 3 | 1 | 5 | 6 | 387 | 15.5 |
30 to 34 years | 420 | 13 | 17 | 14 | 17 | 9 | 6 | 7 | 6 | 6 | 7 | 522 | 20.9 |
35 to 39 years | 300 | 22 | 16 | 9 | 17 | 7 | 9 | 7 | 4 | 5 | 8 | 404 | 16.2 |
40 to 44 years | 237 | 18 | 14 | 8 | 14 | 13 | 6 | 7 | 7 | 8 | 9 | 341 | 13.7 |
45 to 49 years | 128 | 10 | 6 | 5 | 14 | 7 | 7 | 6 | 5 | 12 | 5 | 205 | 8.2 |
50 to 54 years | 61 | 6 | 6 | 5 | 6 | 1 | 4 | 0 | 6 | 7 | 3 | 105 | 4.2 |
55 to 59 years | 65 | 6 | 3 | 1 | 2 | 5 | 6 | 3 | 1 | 4 | 1 | 97 | 3.9 |
≥ 60 years | 99 | 1 | 4 | 3 | 3 | 1 | 3 | 2 | 1 | 3 | 0 | 120 | 4.8 |
Subtotal | 1,894 | 91 | 81 | 61 | 86 | 58 | 52 | 40 | 36 | 53 | 42 | 2,494 | 100.0 |
Age group not reported | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
TotalFootnote 5 | 1,894 | 91 | 81 | 61 | 86 | 58 | 52 | 40 | 36 | 53 | 42 | 2,494 |
Exposure category | Year of diagnosis | Total | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1979-2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | ||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | %Footnote 4 | |
MSM | 13,519 | 67.7 | 41 | 27.7 | 37 | 23.9 | 34 | 27.9 | 34 | 25.8 | 25 | 25.0 | 20 | 20.8 | 13,710 | 66.1 |
MSM/IDU | 907 | 4.5 | 6 | 4.1 | 9 | 5.8 | 1 | 0.8 | 2 | 1.5 | 2 | 2.0 | 2 | 2.1 | 929 | 4.5 |
IDU | 1,833 | 9.2 | 54 | 36.5 | 66 | 42.6 | 40 | 32.8 | 45 | 34.1 | 28 | 28.0 | 26 | 27.1 | 2,092 | 10.1 |
Blood/blood products | ||||||||||||||||
a) recipient of blood | 359 | 1.8 | 2 | 1.4 | 1 | 0.6 | 2 | 1.6 | 1 | 0.8 | 0 | 0.0 | 2 | 2.1 | 367 | 1.8 |
b) recipient of clotting factor | 250 | 1.3 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 250 | 1.2 |
Heterosexual contact | ||||||||||||||||
a) origin from an HIV-endemic country | 1,278 | 6.4 | 9 | 6.1 | 5 | 3.2 | 10 | 8.2 | 8 | 6.1 | 3 | 3.0 | 4 | 4.2 | 1,317 | 6.4 |
b) sexual contact with a person at risk | 1,067 | 5.3 | 11 | 7.4 | 16 | 10.3 | 15 | 12.3 | 18 | 13.6 | 19 | 19.0 | 15 | 15.6 | 1,161 | 5.6 |
c) NIR-Het | 739 | 3.7 | 24 | 16.2 | 19 | 12.3 | 18 | 14.8 | 21 | 15.9 | 22 | 22.0 | 22 | 22.9 | 865 | 4.2 |
Perinatal transmission | 1 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.0 |
Occupational exposure | 21 | 0.1 | 0 | 0.0 | 1 | 0.6 | 2 | 1.6 | 3 | 2.3 | 1 | 1.0 | 5 | 5.2 | 33 | 0.2 |
Other | 7 | 0.0 | 1 | 0.7 | 1 | 0.6 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 9 | 0.0 |
Subtotal | 19,981 | 100.0 | 148 | 100.0 | 155 | 100.0 | 122 | 100.0 | 132 | 100.0 | 100 | 100.0 | 96 | 100.0 | 20,734 | 100.0 |
NIR | 727 | 4 | 0 | 2 | 5 | 1 | 0 | 739 | ||||||||
Not reportedFootnote 5 | 1,136 | 142 | 118 | 110 | 85 | 124 | 91 | 1,806 | ||||||||
Total | 21,844 | 294 | 273 | 234 | 222 | 225 | 187 | 23,279 |
Exposure category | Year of diagnosis | Total | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1979-2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | ||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | %Footnote 4 | |
MSM | 13,519 | 74.5 | 41 | 35.7 | 37 | 29.6 | 34 | 36.2 | 34 | 32.4 | 25 | 36.2 | 20 | 27.0 | 13,710 | 73.2 |
MSM/IDU | 907 | 5.0 | 6 | 5.2 | 9 | 7.2 | 1 | 1.1 | 2 | 1.9 | 2 | 2.9 | 2 | 2.7 | 929 | 5.0 |
IDU | 1,323 | 7.3 | 35 | 30.4 | 45 | 36.0 | 28 | 29.8 | 31 | 29.5 | 18 | 26.1 | 17 | 23.0 | 1,497 | 8.0 |
Blood/blood products | ||||||||||||||||
a) recipient of blood | 225 | 1.2 | 2 | 1.7 | 1 | 0.8 | 2 | 2.1 | 1 | 1.0 | 0 | 0.0 | 2 | 2.7 | 233 | 1.2 |
b) recipient of clotting factor | 239 | 1.3 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 239 | 1.3 |
Heterosexual contact | ||||||||||||||||
a) origin from an HIV-endemic country | 781 | 4.3 | 9 | 7.8 | 4 | 3.2 | 6 | 6.4 | 5 | 4.8 | 1 | 1.4 | 3 | 4.1 | 809 | 4.3 |
b) sexual contact with a person at risk | 571 | 3.1 | 6 | 5.2 | 14 | 11.2 | 12 | 12.8 | 11 | 10.5 | 11 | 15.9 | 11 | 14.9 | 636 | 3.4 |
c) NIR-Het | 546 | 3.0 | 15 | 13.0 | 14 | 11.2 | 9 | 9.6 | 19 | 18.1 | 12 | 17.4 | 15 | 20.3 | 630 | 3.4 |
Perinatal transmission | 1 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.0 |
Occupational exposure | 5 | 0.0 | 1 | 0.9 | 1 | 0.8 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 7 | 0.0 |
Other | 18 | 0.1 | 0 | 0.0 | 0 | 0.0 | 2 | 2.1 | 2 | 1.9 | 0 | 0.0 | 4 | 5.4 | 26 | 0.1 |
Subtotal | 18,135 | 100.0 | 115 | 100.0 | 125 | 100.0 | 94 | 100.0 | 105 | 100.0 | 69 | 100.0 | 74 | 100.0 | 18,717 | 100.0 |
NIR | 660 | 4 | 0 | 2 | 4 | 1 | 0 | 671 | ||||||||
Not reportedFootnote 5 | 831 | 105 | 89 | 86 | 63 | 84 | 55 | 1,313 | ||||||||
TotalFootnote 6 | 19,626 | 224 | 214 | 182 | 172 | 154 | 129 | 20,701 |
Exposure category | Year of diagnosis | Total | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1979-2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | ||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | %Footnote 4 | |
IDU | 509 | 27.6 | 19 | 57.6 | 21 | 70.0 | 11 | 40.7 | 14 | 51.9 | 10 | 32.3 | 9 | 42.9 | 593 | 29.4 |
Blood/blood products | ||||||||||||||||
a) recipient of blood | 134 | 7.3 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 134 | 6.7 |
b) recipient of clotting factor | 11 | 0.6 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 11 | 0.5 |
Heterosexual contact | ||||||||||||||||
a) origin from an HIV-endemic country | 497 | 26.9 | 0 | 0.0 | 1 | 3.3 | 4 | 14.8 | 3 | 11.1 | 2 | 6.5 | 1 | 4.8 | 508 | 25.2 |
b) sexual contact with a person at risk | 496 | 26.9 | 5 | 15.2 | 2 | 6.7 | 3 | 11.1 | 7 | 25.9 | 8 | 25.8 | 3 | 14.3 | 524 | 26.0 |
c) NIR-Het | 193 | 10.5 | 9 | 27.3 | 5 | 16.7 | 9 | 33.3 | 2 | 7.4 | 10 | 32.3 | 7 | 33.3 | 235 | 11.7 |
Occupational exposure | 2 | 0.1 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 2 | 0.1 |
Other | 3 | 0.2 | 0 | 0.0 | 1 | 3.3 | 0 | 0.0 | 1 | 3.7 | 1 | 3.2 | 1 | 4.8 | 7 | 0.3 |
Subtotal | 1,845 | 100.0 | 33 | 100.0 | 30 | 100.0 | 27 | 100.0 | 27 | 100.0 | 31 | 100.0 | 21 | 100.0 | 2,014 | 100.0 |
NIR | 66 | 0 | 0 | 0 | 1 | 0 | 0 | 67 | ||||||||
Not reportedFootnote 5 | 187 | 24 | 19 | 13 | 8 | 21 | 20 | 292 | ||||||||
TotalFootnote 6 | 2,098 | 57 | 49 | 40 | 36 | 52 | 41 | 2,373 |
Exposure category | Year of diagnosis | Total | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1979-2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | ||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | %Footnote 4 | |
Blood/blood products | ||||||||||||||||
a) recipient of blood | 21 | 9.6 | 0 | - | 0 | 0.0 | 0 | - | 0 | - | 0 | 0.0 | 0 | 0.0 | 21 | 9.5 |
b) recipient of clotting factor | 12 | 5.5 | 0 | - | 0 | 0.0 | 0 | - | 0 | - | 0 | 0.0 | 0 | 0.0 | 12 | 5.4 |
Perinatal transmission | 178 | 81.3 | 0 | - | 1 | 100.0 | 0 | - | 0 | - | 1 | 100.0 | 0 | 0.0 | 180 | 81.1 |
OtherFootnote 5 | 8 | 3.7 | 0 | - | 0 | 0.0 | 0 | - | 0 | - | 0 | 0.0 | 1 | 100.0 | 9 | 4.1 |
Subtotal | 219 | 100.0 | 0 | - | 1 | 100.0 | 0 | - | 0 | - | 1 | 100.0 | 1 | 100.0 | 222 | 100.0 |
NIR | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | ||||||||
Not reportedFootnote 6 | 16 | 1 | 2 | 0 | 1 | 0 | 0 | 20 | ||||||||
Total | 244 | 1 | 3 | 0 | 1 | 1 | 1 | 251 |
Exposure category | Age group (years) | Total | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
15-19 | 20-24 | 25-29 | 30-34 | 35-39 | 40-44 | 45-49 | 50-54 | 55-59 | ≥ 60 | ||
MSM | 13 | 309 | 1,632 | 3,010 | 3,114 | 2,494 | 1,617 | 772 | 419 | 330 | 13,710 |
MSM/IDU | 4 | 61 | 184 | 243 | 183 | 124 | 72 | 33 | 20 | 5 | 929 |
IDU | 14 | 88 | 255 | 438 | 478 | 376 | 233 | 136 | 56 | 18 | 2,092 |
Blood/blood products | |||||||||||
a) recipient of blood | 9 | 16 | 28 | 43 | 45 | 37 | 34 | 30 | 40 | 85 | 367 |
b) recipient of clotting factor | 25 | 21 | 44 | 38 | 42 | 24 | 19 | 16 | 10 | 11 | 250 |
Heterosexual contact | |||||||||||
a) origin from an HIV-endemic country | 4 | 57 | 210 | 323 | 279 | 211 | 106 | 53 | 24 | 50 | 1,317 |
b) sexual contact with a person at risk | 4 | 47 | 130 | 199 | 179 | 172 | 145 | 95 | 85 | 105 | 1,161 |
c) NIR-Het | 1 | 30 | 75 | 145 | 121 | 132 | 108 | 98 | 65 | 90 | 865 |
Perinatal transmission | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Occupational exposure | 0 | 0 | 0 | 0 | 2 | 2 | 1 | 2 | 1 | 1 | 9 |
Other | 1 | 0 | 0 | 2 | 5 | 12 | 6 | 4 | 2 | 1 | 33 |
Subtotal | 76 | 629 | 2,558 | 4,441 | 4,448 | 3,584 | 2,341 | 1,239 | 722 | 696 | 20,734 |
NIR | 3 | 24 | 83 | 117 | 151 | 120 | 90 | 67 | 39 | 45 | 739 |
Not reportedFootnote 4 | 15 | 57 | 141 | 274 | 308 | 308 | 288 | 150 | 125 | 140 | 1,806 |
Total | 94 | 710 | 2,782 | 4,832 | 4,907 | 4,012 | 2,719 | 1,456 | 886 | 881 | 23,279 |
Race/ethnicity | Year of diagnosis | Total | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1979-2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | ||||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | %Footnote 5 | |||
AboriginalFootnote 6 | 749 | 4.4 | 36 | 25.5 | 49 | 32.7 | 37 | 30.1 | 42 | 30.9 | 32 | 33.7 | 32 | 34.0 | 977 | 5.5 | ||
South Asian/West Asian/ArabFootnote 7 | 179 | 1.0 | 1 | 0.7 | 1 | 0.7 | 5 | 4.1 | 4 | 2.9 | 0 | 0.0 | 1 | 1.1 | 191 | 1.1 | ||
AsianFootnote 8 | 289 | 1.7 | 7 | 5.0 | 8 | 5.3 | 7 | 5.7 | 8 | 5.9 | 7 | 7.4 | 8 | 8.5 | 334 | 1.9 | ||
BlackFootnote 9 | 1,582 | 9.3 | 10 | 7.1 | 7 | 4.7 | 11 | 8.9 | 11 | 8.1 | 9 | 9.5 | 11 | 11.7 | 1,641 | 9.2 | ||
Latin AmericanFootnote 10 | 287 | 1.7 | 3 | 2.1 | 2 | 1.3 | 2 | 1.6 | 1 | 0.7 | 3 | 3.2 | 1 | 1.1 | 299 | 1.7 | ||
White | 13,859 | 81.3 | 84 | 59.6 | 82 | 54.7 | 60 | 48.8 | 69 | 50.7 | 44 | 46.3 | 38 | 40.4 | 14,236 | 80.0 | ||
Other | 105 | 0.6 | 0 | 0.0 | 1 | 0.7 | 1 | 0.8 | 1 | 0.7 | 0 | 0.0 | 3 | 3.2 | 111 | 0.6 | ||
Subtotal | 17,050 | 100.0 | 141 | 100.0 | 150 | 100.0 | 123 | 100.0 | 136 | 100.0 | 95 | 100.0 | 94 | 100.0 | 17,789 | 100.0 | ||
Not reportedFootnote 11 | 5,042 | 155 | 126 | 111 | 87 | 131 | 94 | 5,746 | ||||||||||
Total | 22,092 | 296 | 276 | 234 | 223 | 226 | 188 | 23,535 |
Province/territory | Number of cases | Ratio | Total | |
---|---|---|---|---|
Males | Females | Males : Females | ||
British Columbia | 4,746 | 544 | 9:1 | 5,290 |
Yukon | 7 | 4 | 2:1 | 11 |
Alberta | 1,463 | 177 | 8:1 | 1,640 |
Northwest Territories | 16 | 5 | 3:1 | 21 |
NunavutFootnote 1 | 0 | 0 | N/A | 0 |
Saskatchewan | 291 | 94 | 3:1 | 385 |
Manitoba | 245 | 50 | 5:1 | 295 |
Ontario | 8,115 | 823 | 10:1 | 8,938 |
QubecFootnote 2 | 5,373 | 725 | 7:1 | 6,098 |
New Brunswick | 164 | 20 | 8:1 | 184 |
Nova Scotia | 323 | 31 | 10:1 | 354 |
Prince Edward IslandFootnote 3 | 20 | 1 | 20:1 | 21 |
Newfoundland and LabradorFootnote 4 | 71 | 20 | 4:1 | 91 |
TotalFootnote 5 | 20,834 | 2,494 | 8:1 | 23,328 |
Province/territory | Year of diagnosis | Total | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1979-2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | n | % | |
British Columbia | 4,342 | 174 | 163 | 143 | 142 | 126 | 112 | 95 | 74 | 68 | 55 | 5,494 | 23.3 |
Yukon | 8 | 0 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 0 | 0 | 11 | 0.0 |
Alberta | 1,216 | 35 | 58 | 60 | 61 | 38 | 34 | 32 | 42 | 32 | 32 | 1,640 | 7.0 |
Northwest Territories | 19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 21 | 0.1 |
NunavutFootnote 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 |
Saskatchewan | 211 | 9 | 6 | 6 | 10 | 10 | 25 | 23 | 36 | 22 | 27 | 385 | 1.6 |
Manitoba | 239 | 9 | 14 | 8 | 6 | 3 | 4 | 3 | 7 | 2 | 0 | 295 | 1.3 |
Ontario | 7,807 | 196 | 142 | 145 | 141 | 114 | 93 | 76 | 58 | 100 | 69 | 8,941 | 38.0 |
QuebecFootnote 2 | 6,098 | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | 6,098 | 25.9 |
New Brunswick | 162 | 6 | 2 | 4 | 1 | 2 | 1 | 1 | 2 | 1 | 2 | 184 | 0.8 |
Nova Scotia | 309 | 5 | 13 | 5 | 6 | 2 | 5 | 4 | 3 | 0 | 2 | 354 | 1.5 |
Prince Edward IslandFootnote 3 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | NR | NR | 21 | 0.1 |
Newfoundland and LabradorFootnote 4 | 91 | 0 | 0 | 0 | 0 | NR | NR | NR | NR | NR | NR | 91 | 0.4 |
Total | 20,522 | 434 | 398 | 371 | 367 | 296 | 276 | 234 | 223 | 226 | 188 | 23,535 | 100.0 |
Province/territory | Year of diagnosis | Total | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1979-2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | n | % | |
British Columbia | 3,918 | 125 | 128 | 113 | 107 | 88 | 76 | 72 | 53 | 38 | 28 | 4,746 | 22.8 |
Yukon | 4 | 0 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 0 | 0 | 7 | 0.0 |
Alberta | 1,120 | 30 | 46 | 49 | 52 | 31 | 30 | 26 | 34 | 21 | 24 | 1,463 | 7.0 |
Northwest Territories | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 16 | 0.1 |
NunavutFootnote 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 |
Saskatchewan | 175 | 5 | 6 | 4 | 5 | 5 | 21 | 14 | 23 | 12 | 21 | 291 | 1.4 |
Manitoba | 210 | 7 | 5 | 4 | 5 | 3 | 2 | 2 | 5 | 2 | 0 | 245 | 1.2 |
Ontario | 7,208 | 154 | 110 | 125 | 102 | 93 | 77 | 64 | 52 | 79 | 51 | 8,115 | 39.0 |
QuebecFootnote 2 | 5,373 | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | 5,373 | 25.8 |
New Brunswick | 146 | 5 | 1 | 3 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 164 | 0.8 |
Nova Scotia | 285 | 3 | 12 | 3 | 5 | 2 | 5 | 3 | 3 | 0 | 2 | 323 | 1.6 |
Prince Edward IslandFootnote 3 | 19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | NR | NR | 20 | 0.1 |
Newfoundland and LabradorFootnote 4 | 71 | 0 | 0 | 0 | 0 | NR | NR | NR | NR | NR | NR | 71 | 0.3 |
TotalFootnote 5 | 18,543 | 329 | 308 | 301 | 277 | 224 | 214 | 182 | 173 | 154 | 129 | 20,834 | 100.0 |
Province/territory | Year of diagnosis | Total | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1979-2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | n | % | |
British Columbia | 340 | 35 | 26 | 21 | 31 | 24 | 26 | 11 | 8 | 12 | 10 | 544 | 21.8 |
Yukon | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0.2 |
Alberta | 96 | 5 | 12 | 11 | 9 | 7 | 4 | 6 | 8 | 11 | 8 | 177 | 7.1 |
Northwest Territories | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 0.2 |
NunavutFootnote 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 |
Saskatchewan | 36 | 4 | 0 | 2 | 5 | 5 | 4 | 9 | 13 | 10 | 6 | 94 | 3.8 |
Manitoba | 29 | 2 | 9 | 4 | 1 | 0 | 2 | 1 | 2 | 0 | 0 | 50 | 2.0 |
Ontario | 598 | 42 | 32 | 20 | 39 | 21 | 16 | 12 | 5 | 20 | 18 | 823 | 33.0 |
QuebecFootnote 2 | 725 | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | 725 | 29.1 |
New Brunswick | 16 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 20 | 0.8 |
Nova Scotia | 24 | 2 | 1 | 2 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 31 | 1.2 |
Prince Edward IslandFootnote 3 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | NR | NR | 1 | 0.0 |
Newfoundland and LabradorFootnote 4 | 20 | 0 | 0 | 0 | 0 | NR | NR | NR | NR | NR | NR | 20 | 0.8 |
TotalFootnote 5 | 1,894 | 91 | 81 | 61 | 86 | 58 | 52 | 40 | 36 | 53 | 42 | 2,494 | 100.0 |
Exposure category | Province/territory | Total | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BC | YT | AB | NT/NUFootnote 1 | SK | MB | ONFootnote 2 | QCFootnote 3 | NB | NS | PEFootnote 4 | NLFootnote 5 | |||||||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | %Footnote 6 | |
MSM | 2,882 | 61.6 | 1 | 10.0 | 986 | 62.6 | 7 | 33.3 | 103 | 27.6 | 149 | 51.7 | 5,392 | 72.3 | 3,798 | 64.2 | 98 | 55.1 | 239 | 67.7 | 16 | 84.2 | 42 | 46.7 | 13,713 | 65.4 |
MSM/IDU | 269 | 5.7 | 1 | 10.0 | 31 | 2.0 | 1 | 4.8 | 17 | 4.6 | 10 | 3.5 | 294 | 3.9 | 283 | 4.8 | 10 | 5.6 | 12 | 3.4 | 0 | 0.0 | 2 | 2.2 | 930 | 4.4 |
IDU | 849 | 18.1 | 5 | 50.0 | 184 | 11.7 | 2 | 9.5 | 158 | 42.4 | 35 | 12.2 | 360 | 4.8 | 461 | 7.8 | 11 | 6.2 | 24 | 6.8 | 0 | 0.0 | 4 | 4.4 | 2,093 | 10.0 |
Blood/blood products | ||||||||||||||||||||||||||
a) recipient of blood | 80 | 1.7 | 0 | 0.0 | 29 | 1.8 | 1 | 4.8 | 4 | 1.1 | 8 | 2.8 | 163 | 2.2 | 84 | 1.4 | 4 | 2.2 | 11 | 3.1 | 0 | 0.0 | 4 | 4.4 | 388 | 1.9 |
b) recipient of clotting factor | 16 | 0.3 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 15 | 4.0 | 8 | 2.8 | 97 | 1.3 | 86 | 1.5 | 23 | 12.9 | 7 | 2.0 | 2 | 10.5 | 8 | 8.9 | 262 | 1.3 |
Heterosexual contact | ||||||||||||||||||||||||||
a) origin from an HIV-endemic country | 70 | 1.5 | 0 | 0.0 | 79 | 5.0 | 0 | 0.0 | 10 | 2.7 | 14 | 4.9 | 442 | 5.9 | 690 | 11.7 | 4 | 2.2 | 11 | 3.1 | 1 | 5.3 | 1 | 1.1 | 1,322 | 6.3 |
b) sexual contact with a person at risk | 230 | 4.9 | 3 | 30.0 | 74 | 4.7 | 6 | 28.6 | 33 | 8.8 | 24 | 8.3 | 481 | 6.4 | 243 | 4.1 | 15 | 8.4 | 31 | 8.8 | 0 | 0.0 | 22 | 24.4 | 1,162 | 5.5 |
c) NIR-Het | 239 | 5.1 | 0 | 0.0 | 179 | 11.4 | 2 | 9.5 | 30 | 8.0 | 38 | 13.2 | 166 | 2.2 | 179 | 3.0 | 12 | 6.7 | 17 | 4.8 | 0 | 0.0 | 3 | 3.3 | 865 | 4.1 |
Perinatal transmission | 18 | 0.4 | 0 | 0.0 | 8 | 0.5 | 1 | 4.8 | 1 | 0.3 | 2 | 0.7 | 56 | 0.8 | 90 | 1.5 | 0 | 0.0 | 1 | 0.3 | 0 | 0.0 | 4 | 4.4 | 181 | 0.9 |
Occupational exposure | 2 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.3 | 0 | 0.0 | 5 | 0.1 | 1 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 9 | 0.0 |
Other | 24 | 0.5 | 0 | 0.0 | 5 | 0.3 | 1 | 4.8 | 1 | 0.3 | 0 | 0.0 | 2 | 0.0 | 0 | 0.0 | 1 | 0.6 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 34 | 0.2 |
Subtotal | 4,679 | 100.0 | 10 | 100.0 | 1,575 | 100.0 | 21 | 100.0 | 373 | 100.0 | 288 | 100.0 | 7,458 | 100.0 | 5,915 | 100.0 | 178 | 100.0 | 353 | 100.0 | 19 | 100.0 | 90 | 100.0 | 20,959 | 100.0 |
NIR | 186 | 1 | 0 | 0 | 12 | 7 | 349 | 183 | 6 | 1 | 2 | 1 | 748 | |||||||||||||
Not reported | 629 | 0 | 65 | 0 | 0 | 0 | 1,134 | 0 | 0 | 0 | 0 | 0 | 1,828 | |||||||||||||
Total | 5,494 | 11 | 1,640 | 21 | 385 | 295 | 8,941 | 6,098 | 184 | 354 | 21 | 91 | 23,535 |
Year of deathFootnote 4 | HIV deaths recorded by vital statistics |
---|---|
1987 | 524 |
1988 | 660 |
1989 | 850 |
1990 | 982 |
1991 | 1,170 |
1992 | 1,358 |
1993 | 1,562 |
1994 | 1,628 |
1995 | 1,764 |
1996 | 1,306 |
1997 | 626 |
1998 | 484 |
1999 | 431 |
2000 | 511 |
2001 | 435 |
2002 | 405 |
2003 | 440 |
2004 | 420 |
2005 | 468 |
2006 | 428 |
2007 | 422 |
2008 | 407 |
2009 | 355 |
2010 | 336 |
2011 | 303 |
Total | 18,275 |
Age group and sex | Number of deaths | % |
---|---|---|
Children (< 15 years) | 96 | 0.5 |
Males | 49 | 51.0 |
Females | 47 | 49.0 |
Adults (≥ 15 years) | 18,179 | 99.5 |
Males | 16,309 | 89.7 |
Females | 1,870 | 10.3 |
Total | 18,275 | 100.0 |
Males | 16,358 | 89.5 |
Females | 1,917 | 10.5 |
Year of deathFootnote 4 | Adults (≥ 15 years) | Children (< 15 years old) | Total | |||
---|---|---|---|---|---|---|
Number | Cumulative | Number | Cumulative | Number | Cumulative | |
1987 | 518 | 518 | 6 | 6 | 524 | 524 |
1988 | 655 | 1,173 | 5 | 11 | 660 | 1,184 |
1989 | 845 | 2,018 | 5 | 16 | 850 | 2,034 |
1990 | 978 | 2,996 | 4 | 20 | 982 | 3,016 |
1991 | 1,163 | 4,159 | 7 | 27 | 1,170 | 4,186 |
1992 | 1,350 | 5,509 | 8 | 35 | 1,358 | 5,544 |
1993 | 1,553 | 7,062 | 9 | 44 | 1,562 | 7,106 |
1994 | 1,610 | 8,672 | 18 | 62 | 1,628 | 8,734 |
1995 | 1,750 | 10,422 | 14 | 76 | 1,764 | 10,498 |
1996 | 1,298 | 11,720 | 8 | 84 | 1,306 | 11,804 |
1997 | 621 | 12,341 | 5 | 89 | 626 | 12,430 |
1998 | 484 | 12,825 | 0 | 89 | 484 | 12,914 |
1999 | 430 | 13,255 | 1 | 90 | 431 | 13,345 |
2000 | 509 | 13,764 | 2 | 92 | 511 | 13,856 |
2001 | 435 | 14,199 | 0 | 92 | 435 | 14,291 |
2002 | 404 | 14,603 | 1 | 93 | 405 | 14,696 |
2003 | 440 | 15,043 | 0 | 93 | 440 | 15,136 |
2004 | 419 | 15,462 | 1 | 94 | 420 | 15,556 |
2005 | 466 | 15,928 | 2 | 96 | 468 | 16,024 |
2006 | 428 | 16,356 | 0 | 96 | 428 | 16,452 |
2007 | 422 | 16,778 | 0 | 96 | 422 | 16,874 |
2008 | 407 | 17,185 | 0 | 96 | 407 | 17,281 |
2009 | 355 | 17,540 | 0 | 96 | 355 | 17,636 |
2010 | 336 | 17,876 | 0 | 96 | 336 | 17,972 |
2011 | 303 | 18,179 | 0 | 96 | 303 | 18,275 |
Total | 18,179 | 96 | 18,275 |
Year of deathFootnote 4 | Adult males (≥ 15 years) | Adult females (< 15 years old) | Total | |||
---|---|---|---|---|---|---|
Number | Cumulative | Number | Cumulative | Number | Cumulative | |
1987 | 486 | 486 | 32 | 32 | 518 | 518 |
1988 | 611 | 1,097 | 44 | 76 | 655 | 1,173 |
1989 | 793 | 1,890 | 52 | 128 | 845 | 2,018 |
1990 | 934 | 2,824 | 44 | 172 | 978 | 2,996 |
1991 | 1,102 | 3,926 | 61 | 233 | 1,163 | 4,159 |
1992 | 1,284 | 5,210 | 66 | 299 | 1,350 | 5,509 |
1993 | 1,465 | 6,675 | 88 | 387 | 1,553 | 7,062 |
1994 | 1,485 | 8,160 | 125 | 512 | 1,610 | 8,672 |
1995 | 1,628 | 9,788 | 122 | 634 | 1,750 | 10,422 |
1996 | 1,192 | 10,980 | 106 | 740 | 1,298 | 11,720 |
1997 | 550 | 11,530 | 71 | 811 | 621 | 12,341 |
1998 | 414 | 11,944 | 70 | 881 | 484 | 12,825 |
1999 | 364 | 12,308 | 66 | 947 | 430 | 13,255 |
2000 | 428 | 12,736 | 81 | 1,028 | 509 | 13,764 |
2001 | 369 | 13,105 | 66 | 1,094 | 435 | 14,199 |
2002 | 343 | 13,448 | 61 | 1,155 | 404 | 14,603 |
2003 | 373 | 13,821 | 67 | 1,222 | 440 | 15,043 |
2004 | 344 | 14,165 | 75 | 1,297 | 419 | 15,462 |
2005 | 369 | 14,534 | 97 | 1,394 | 466 | 15,928 |
2006 | 346 | 14,880 | 82 | 1,476 | 428 | 16,356 |
2007 | 339 | 15,219 | 83 | 1,559 | 422 | 16,778 |
2008 | 313 | 15,532 | 94 | 1,653 | 407 | 17,185 |
2009 | 285 | 15,817 | 70 | 1,723 | 355 | 17,540 |
2010 | 263 | 16,080 | 73 | 1,796 | 336 | 17,876 |
2011 | 229 | 16,309 | 74 | 1,870 | 303 | 18,179 |
Total | 16,309 | 1,870 | 18,179 |
Country | Cumulative number to 2013Footnote 1 | Number reported in 2013 | All ages rate per 100,000 population for 2013 |
---|---|---|---|
North America and Australia | |||
Canada | 78,425 | 2,076 | 5.9 |
United StatesFootnote 2 | N/A | 41,387 | 15.0Footnote 3 |
AustraliaFootnote 4 | 35,287 | 1,236 | 5.2Footnote 5 |
Western EuropeFootnote 5Footnote 6 | |||
Austria | 7,942 | 260 | 3.1 |
Andorra | 68 | 5 | 6.6 |
Belgium | 26,850 | 1,115 | 10.0 |
Denmark | 6,572 | 233 | 4.2 |
Finland | 3,218 | 157 | 2.9 |
France | 60,047 | 4,002 | 6.1 |
Germany | 48,891 | 3,263 | 4.0 |
Greece | 13,627 | 807 | 7.3 |
Iceland | 310 | 11 | 3.4 |
Ireland | 6,976 | 332 | 7.2 |
Israel | 8,008 | 490 | 6.3 |
Italy | 29,163 | 3,608 | 6.0 |
Luxembourg | 1,251 | 53 | 9.9 |
Malta | 223 | 36 | 8.5 |
Netherlands | 22,044 | 949 | 5.7 |
Norway | 5,370 | 233 | 4.6 |
Portugal | 47,390 | 1,093 | 10.4 |
San Marino | 81 | 0 | 0.0 |
Spain | 29,987 | 3,278 | 7 |
Sweden | 10,787 | 354 | 3.7 |
Switzerland | 33,946 | 574 | 7.1 |
United Kingdom | 133,606 | 5,994 | 9.4 |
Country | Cumulative number to 2013Footnote 1 | Number reported in 2013 | All ages rate per 100,000 population for 2013 |
---|---|---|---|
North America and Australia | |||
Canada | 23,347 | 226 | 0.6 |
United StatesFootnote 2 | 1,182,528 | 23,850 | 8.4Footnote 3 |
AustraliaFootnote 4 | - | - | - |
Western EuropeFootnote 5 | |||
Austria | 3,866 | 70 | 0.8 |
Andorra | 8 | 2 | 2.6 |
Belgium | 4,435 | 78 | 0.7 |
Denmark | 2,927 | 38 | 0.7 |
Finland | 616 | 20 | 0.4 |
France | 69,004 | 404 | 0.6 |
Germany | 29,800 | 241 | 0.3 |
Greece | 3,522 | 118 | 1.1 |
Iceland | 67 | 1 | 0.3 |
Ireland | 1,189 | 26 | 0.6 |
Israel | 2,869 | 39 | 0.5 |
Italy | 66,336 | 1,016 | 1.7 |
Luxembourg | 278 | 9 | 1.7 |
Malta | 103 | 1 | 0.2 |
Netherlands | s4,107 | 199 | 1.2 |
Norway | 1,069 | 28 | 0.6 |
Portugal | 19,075 | 322 | 3.1 |
San Marino | 23 | 0 | 0.0 |
Spain | 83,776 | 604 | 1.6 |
SwedenFootnote 6 | 2,168 | - | - |
Switzerland | 9,534 | 71 | 0.9 |
United Kingdom | 28,224 | 319 | 0.5 |
Page details
- Date modified: